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THE ROLE OF MERLIN AND APICOBASAL POLARITY IN ENDOMETRIAL
DEVELOPMENT AND HOMEOSTASIS
Abstract
Erin Williams Lopez, B.A.
Advisory Professor: Andrew B. Gladden, Ph.D.

Apicobasal polarity and cell adhesion are necessary for the proper formation
and organization of epithelial tissues. Merlin couples cell polarity and adhesion
through correct localization of the polarity protein Par3 and maturation of apical
junctions. Merlin and Par3 are necessary for the development and homeostasis of
highly regenerative tissues like the epidermis. The continual repopulation of the
endometrium after each menstrual cycle requires a constant reorganization of cell
polarity and adhesion. The endometrium consists of a luminal epithelium that
postnatally gives rise to the distinct glandular epithelium. Endometrial glands are
necessary to secrete nutrients for the pre-implantation embryo. In addition, the
endometrial gland is thought to be where endometrial cancer originates. While the
endometrium is important for female fertility, relatively little is understood about how
glands develop or how endometrial cancer forms. We examine the role of Merlin and
apicobasal polarity in endometrial development and homeostasis. We determine that
Merlin regulation of apicobasal polarity is necessary for proper endometrial gland
formation. Apicobasal polarity is disrupted in low-grade endometrial cancer and
mediates Notch regulated proliferation and migration in endometrial cancer cells.
This dissertation reveals a critical role for Merlin and cell polarity in endometrial
gland development, mammalian fertility, and endometrial cancer.
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Chapter 1: Introduction

1.1 Female Reproductive Tract Development
The Female Reproductive Tract (FRT) consists of the vagina, cervix,
uterus, oviducts, and ovaries(1). The FRT originates from the intermediate
mesoderm which differentiates into the urogenital system,(2) containing the
kidneys, urinary system, and FRT in females. The embryonic mesoderm
proliferates and goes through a cell fate change creating two epithelial tubes, the
Wolffian duct and the Mullerian duct. The Wolffian duct initially forms transient
segments that eventually create one continuous tube. The Mullerian duct is
formed when mesonephric epithelial cells invaginate and lengthen adjacent to
the Wolffian duct. FRT development requires Wnt-mediated signals stimulated by
the Wnt4, Wnt5a, and Wnt9b ligands to regulate Mullerian duct formation and
elongation(3–5).
The symmetric Mullerian ducts fuse after elongation, forming the complete
FRT (Figure 1a). Mammalian species differ in the degree of fusion, generating
different types of uteri with duplex, bipartite, or simplex forms (Figure 1b). A
duplex uterus, observed in monotremes and marsupials, results when the uterine
horns never fuse and each has an individual cervix. Duplex uteri are split into
three sub-categories: without a vagina, with two lateral vaginae and central birth
canal, or with a single vagina. Mice have a bipartite uterus (sometimes described
as a bicornuate uterus) that has two separate
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Figure 1 Development of the Uterus.
The Mullerian duct (red line) migrates adjacent to the Wolffian duct (blue line) to form the
primordial FRT(a, i-v). Once the Mullerian duct is fully formed, the Wolffian duct will
begin to disintegrate in genetic females (a, v-vii). During disintegration of the Wolffian
duct, the Mullerian duct will also differentiate into the Female reproductive tract (FRT) (a,
vii-x). There are three types of FRT: (i) duplex, (ii) bipartite, and (iii) simplex. There are
three subcategories of duplex FRTs do not have a vagina, have two vaginae, and one
that has one vagina. There are a wide variety of bipartite FRTs including the two
examples provided. Both exhibit two uterine horns with varying levels of connection and
one cervix. A simplex FRT has two oviducts that connect to a single uterus (b). A
diagram of a uterus cross-section (c). The outer layers of the uterus include two different
myometrial layers. The innermost layer is the luminal epithelium with glandular
epithelium strewn throughout the endometrial stroma surrounding the luminal epithelium
(c). Endometrial gland development does not begin in most mammals until after birth (d).
The luminal epithelium of the endometrium (tan) will begin to bud (i) off the main lumen
(green). These buds will (ii) form teardrops, (iii) create elongated tubules, (iv) and
eventually form sinuous and branched tubules. After puberty, the tubules will form an
extensive secondary branching off the main glandular trunk (d).
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uterine horns connected by a central cervix. In some species with a bipartite
uterus, the uterine body is fused but still exhibits separate horns (Figure 1b).
Finally, a few bat species and some primates like the human have a simplex
uterus where the fusion of the Mullerian duct is more extensive, creating one
central uterus with two separate oviducts and ovaries. Mice are commonly
utilized to investigate mammalian FRT development, as it closely represents
human FRT development(6, 7).
Following the completion of Mullerian duct fusion, the Wolffian duct will
regress in females (Figure 1a, blue). The differentiation of the Mullerian duct is
driven by both repression or absence of signals like androgens and the activation
of other signals like COUP-TFII (COUP transcription factor 2)(8). Mullerian
differentiation leads to the formation of the oviduct, uterus, cervix, and upper
vagina. This differentiation is regulated by a large number of proteins including
multiple homeodomain transcription factors (Hox). There are specific Hox genes
that pattern the different regions of the FRT. Hoxa9 is expressed during oviduct
formation, Hoxa10 and Hoxa11 are required for uterine differentiation, and
Hoxa13 promotes cervical and vaginal differentiation(9). Disruption of the Hox
patterning, by loss of Hoxa10 and Hoxa11 in mice, for example, causes a portion
of the uterus to differentiate into oviduct(10). Similarly, Hoxa13 loss in mice
causes the cervix to differentiate into uterus(11). Interestingly, in addition to
development driven by Hox expression, the Wnt ligand, Wnt7a, also causes
aberrant differentiation of the oviduct into uterus and the uterus into vagina(12).
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The differentiation of the fused Mullerian duct structure results in numerous,
morphologically diverse tissues. The upper vagina has a stratified squamous
epithelium surrounded by a double layer of smooth muscle. The cervix has two
distinct areas. One has a stratified squamous epithelium that is encased in a
stromal layer, while the other area is a folded simple columnar epithelium that
creates mucosal glands. The oviducts have three different portions: the
infundibulum (close to the ovary), the ampulla, and the isthmus (closest to the
uterus). The infundibulum actively helps move the egg released from the ovary
into the oviduct. The ampulla is commonly where an egg is fertilized. The isthmus
is a small portion of the oviduct that is connected to the uterus. The uterus is
made up of the exterior layer, perimetrium, the myometrium, and the
endometrium, the innermost layer (Figure 1c). The perimetrium is a thin
membrane with a layer of connective tissue underneath that is the exterior of the
uterus. The myometrium, derived from the Mullerian duct mesenchyme, is
divided into two histologically distinct sets of smooth muscle (Figure 1c). The
longitudinal myometrium is the outermost layer, while the radial myometrium is
the inner layer. The endometrium consists of stroma, vasculature, and a simple
columnar epithelium. The simple columnar epithelium develops after birth into
two distinct populations: luminal epithelium and glandular epithelium (Figure 1c).
The luminal epithelium is found on the main central lumen in the uterus and the
glandular epithelium extends from the main lumen (Figure 1c). At birth, mice
have formed a bipartite uterus, but lack the endometrial glands necessary for
reproduction.

5

After puberty, a mammal will start ovulation through menstruation or estrous.
The menstrual cycle length is determined by the first day of menses to the day
before the menses of the next cycle begins. In humans the cycle is between 2530 days in length(13). During this time a group of ovarian follicles will mature with
one eventually dominating the other follicles until the oocyte is released in
ovulation(13). Meanwhile, the endometrium is primed by estrogen to proliferate
and form a proper environment for an embryo(13). Once the egg is released, the
follicular cells that have not been released secrete progesterone to prepare the
uterus for implantation of the zygote(13). If implantation does not occur, then the
follicular cells degrade and menstruation begins when progesterone and
estrogen levels are at their lowest point(13). The estrous cycle is divided into four
stages: diestrus, proestrus, estrus, and metestrus(14). During diestrus, small
follicles are present that begin to grow in proestrus(14). At the same time, the
uterus begins to vascularize, endometrial glands grow, and the epithelium
increases so that by estrus, there is a maximum amount of growth in the uterus.
Estrus is when ovulation begins, where 10-20 eggs are released in mice from the
ovarian follicles. Metestrus is similar to the beginning of menses. However, the
tissue is not shed but rather reabsorbed into the uterus(14).
This cycling is utilized to prime the female uterus for reproduction. Once an
oocyte is fertilized the endometrial glands play a critical role in readying the
uterine environment for the embryo. During the fertilization process the
endometrial glands secrete proteins which (1) makes the uterus receptive to the
blastocyst when it implants, (2) differentiates the endometrial stroma into decidua
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and (3) nurtures the embryo during the generation of a placenta(15–18). The
endometrial gland is a necessary part of female fertility that begins developing
postnatally.

1.2 Endometrial Gland Development
Endometrial glands begin to bud in mice (Mus musculus) between
postnatal day 5 (P5) and P7 from the luminal epithelium. Gland development
does not happen as a synchronous event and each gland may be at a different
stage of development. Around P7 endometrial glands begin to form teardrop-like
structures(19) which then elongate into tubes around P11 that begin to branch by
P21(19). After puberty, the glands look similar to a multi-branched tree, with the
top of the tree connected to the central lumen (Figure 1d)(20). The endometrial
gland epithelium can be distinguished from the luminal epithelium by expression
of Foxa2 and increased Sox9 nuclear expression(21, 22).
Gland development is a complex and dynamic process that takes the
coordination of the luminal epithelium, the differentiating glandular epithelium, the
endometrial stroma and the two layers of myometrium in order to form properly.
Over the past two decades, scientists have been working to understand the
complex molecular mechanism of this glandular development. There are a large
number of genes that are involved in endometrial gland development (Table 1,
Function: Gland Development). Utilizing a uterine specific Cre driven by the
progesterone receptor (PR-Cre), it was found that Ctnnb1lox/lox; PR-Cre,
Wnt7alox/lox; PR-Cre, and Wnt5alox/lox; PR-Cre mice do not form endometrial
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glands. Wnt4-/- mice have a decrease in the number of glands compared to wildtype endometrium when examined in kidney capsule grafting experiments(23). In
addition, exposing postnatal mice from P3-P11 to high levels of progesterone
causes a loss of gland formation that corresponds to a decrease in canonical
Wnt signaling(24). Similar to Wnt signaling mutants, Sox17lox/lox; PR- Cre mice
have an aglandular phenotype but curiously Sox17 is known as a negative
regulator of Wnt signaling(25). Mice with increased Notch signaling in the uterus,
Rosa26N1ICD/N1ICD; PR-Cre, do not form endometrial glands. This implicates
numerous membrane receptor signaling pathways in endometrial adenogenesis,
especially Wnt signaling(26).

1.3 Wnt signaling
Wnt signaling is associated with three different pathways, canonical, noncanonical planar cell polarity, and the non-canonical calcium pathway (Figure
2a). In planar cell polarity (PCP), Wnt ligands bind with Frizzled receptors leading
to the recruitment of PCP protein DVL (dishevelled) which activates RAC (Rasrelated C3 botulinum toxin substrate), Cdc42 (cell division control protein 42),
and RhoA (Ras homolog gene family member A) to affect actin organization
(Figure 2a). The calcium/Wnt signaling begins with Wnt ligands binding to
Frizzled receptors and ROR (retinoid-related orphan receptors) activating an
assortment of kinases like JNK (Jun Kinase) and Protein Kinase C (PKC) (Figure
2a). The most widely studied pathway however is the canonical Wnt signaling
pathway. In canonical Wnt signaling, the Frizzled receptors bind with the LRP5/6
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Function

Genetic
Manipulation

Female Reproductive-tract
phenotype

References

Aromatase

Development

Null

Underdeveloped uteri

(27)

Hoxa11

Development

Null

(10)

Vangl2

Development

Spontaneous
mutation;
Grafting
Experiments

Follistatin

Development;
Differentiation

Conditional
Knockout

Development;
Differentiation

Transheterozy
gotes

Excessive narrowing of the uterus
Septate vagina; Heterozygous mice
have reduced gland formation;
Mislocalization of E-cadherin;
Disruption of planar cell polarity;
Loss of actin polarization; Infertile
Subfertile; poor decidualization;
Abnormal endometrial luminal
epithelium receptivity
Partial transformation of uterus to
oviduct; Excessive narrowing of the
uterus

Differentiation

Conditional
Knockout

(30)

Differentiation

Null

Estrogen
receptor a/b

Differentiation

Null

Hoxa10

Differentiation

Hoxa13

Differentiation

Null
Hypodactyly
mutation

IGF-1

Differentiation

Null

Ovo1

Differentiation

Null

Wnt7a

Differentiation
; Gland
Development

Null;
Conditional
Knockout

PTEN

Differentiation
; homeostasis

Conditional
Knockout

Subfertile; poor decidualization
Sterile; hypoplastic; does not go
through estrous cycle
Extreme hypoplastic uterus;
abnormal uterine architecture;
sterile
Partial transformation of uterus to
oviduct
Cervical tissue transformed into
uterus; hypoplasia of the vagina
Underdeveloped uteri especially in
myometrium
Dilated uterus; Loss of luminal
epithelium
Uterine tissue transformed into
vagina and oviduct transformed
into uterus; Loss of uterine glands,
Abnormal mesenchyme
differentiation
At 1 month had endometrial
cancer; 3 months endometrial
cancer with myometrial invasion
Reduced gland formation with few
aberrantly in myometrium;
decreased endometrial size;
dysfunction of the uterotubal
junction; reduced oviducts and
uterine horns
Reduced gland formation; large
lumen with deep invaginations
Reduced gland formation; subfertile

(21)

Loss of uterine glands

(39)

Loss of uterine glands; infertile;
misregulation of hormone signaling

(26)

Loss of uterine glands; infertile;
increased endometrial epithelial
cell death

(40)

Gene Name

Hoxa10/Hoxa11
Activin-like
Kinase 2
(ALK2)
Estrogen
receptor a

Lef1

Gland
Development
Gland
Development
Gland
Development
Gland
Development

Notch1

Gland
Development

Dicer
Dlx5/6
Foxa2

PR-Set7

Gland
Development

Stroma
Conditional
Knockout
Conditional
Knockout
Conditional
Knockout
Null
Overactivation
Conditional
Knockout

(28)
(29)
(10)

(31)
(31)
(10)
(32)
(33)
(34)

(35)
(36)

(37)
(38)
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Progesterone

Gland
Development

Increased
amount at
early postnatal
days

Sox17

Gland
Development

Conditional
Knockoutstroma

Sox9

Gland
Development

Overactivation

Increase in uterine gland formation;
uterine cysts

(22)

Late onset Increase in uterine
gland formation; Abnormal
endometrial luminal epithelium and
shape

(42)

Early increases in gland numbers

(43)

Short & coiled uterine horns, lack of
cervical/vaginal structures; loss of
uterine glands

(4)

Reduced gland formation,
abnormal luminal epithelium

(23)

Timp1

Gland
Development

Null

Wnt11

Gland
Development

Conditional
Knockout

Wnt5a

Gland
Development,
Differentiation

Null

Wnt4

Gland
Development,
Homeostasis

Conditional
Knockout

Lgr4

Gland
Development,
Pregnancy

Conditional
Knockout

Cdh1

Gland
Development;
Homeostasis

Conditional
Knockout

Loss of uterine glands; Infertile;
impaired decidualization; no
implantation and decreased
implantation factors

(41)

Loss of uterine glands; infertile

(25)

Reduced gland formation;
decreased LIF secretion; subfertile;
impaired decidualization
Loss of uterine glands; Loss of
epithelial markers; Loss of
endometrial stroma markers;
Increased apoptosis and
proliferation; Decreased Wnt and
Hox expression

(44)

(45)

Smo

Gland
Development;
Homeostasis
Gland
Development;
Homeostasis;
Stromal
Development

Overactivation

Loss of uterine glands, later k14
positive stratified squamous
epithelium; unable to go through
decidualization reaction
Infertile; No decidualization; Uterine
hypertrophy; reduced gland
formation; stratified squamous
luminal epithelium; Uterine stroma
change extracellular matrix

Ctnnb1

Homeostasis

Overactivation

Hyperplasia of the gland

(46)

Estrogen
receptor b

Pregnancy

Null

Subfertile (smaller litters)

(48)

Kiss1

Pregnancy

Null

Decreased Lif1 secretion levels

(49)

Lif

Pregnancy

Null

Inability of blastocyst to implant; No
decidualization

(15, 16)

Ctnnb1

Conditional
Knockout

Conditional
Notch1
Pregnancy
Knockout
Reduced decidualization
Table 1 Genes involved with Uterus Development and Homeostasis

(46)

(47)

(50)
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(low density lipoprotein receptor related protein 5/6) co-receptors causing DVL to
be phosphorylated which recruits a scaffolding protein, Axin. Axin in complex with
APC (adenomatous polyposis coli), CK1a (Casein kinase 1a) and GSK-3b
(glycogen synthase kinase 3b) create the destruction complex. This complex
targets b-catenin for multiple phosphorylation events leading to recruitment of the
ubiquitin ligase complex which ubiquitinates b-catenin and leads to proteasomal
degradation. Thus, when Axin is recruited away from this complex, b-catenin is
able to translocate into the nucleus and bind with the LEF/TCF (Lymphoid
enhancer factor/T-cell factor) family of proteins derepressing downstream Wnt
target genes (Table 2). Interestingly, while b-catenin is a key component of
canonical Wnt signaling, the majority of b-catenin is found at adherens junctions.
There is a debate on whether junctional b-catenin and cytoplasmic b-catenin
pools mix. Another adherens junction protein was also recently found to play a
role in Wnt signaling, a-catenin. a-catenin increases APC binding to b-catenin
allowing for increased degradation of b-catenin and in theory a decrease in
canonical Wnt signaling(51). Wnt signaling is thought to be a major pathway in
endometrial development. As was previously discussed Wnt ligands and bcatenin were found to affect both Mullerian duct formation and endometrial
adenogenesis. Since the loss of b-catenin disrupts endometrial adenogenesis,
we can postulate that canonical Wnt signaling is necessary during endometrial
gland development. Many of the Wnt ligands, mentioned in section 1.1 Female
Reproductive Tract Development, that are associated with endometrial gland
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Figure 2 Wnt, Notch, and Hippo signaling pathways.
There are three main types of Wnt signaling (i) canonical signaling, (ii) non-canonical
calcium signaling, (iii) planar cell polarity (a). (i) When Frizzled receptors are activated by
LRP in canonical Wnt signaling it inhibits the destruction complex
(Axin/APC/GSK3b) from phosphorylating b-catenin. b-catenin is then able to translocate
to the nucleus where it increases canonical Wnt target genes. (ii) Frizzled receptors and
retinoid-related orphan receptors (RORs) bind to the Wnt ligand activating
Phospholipase C (PLC) which in turn activates many different proteins including Inositol
trisphosphate (IP3) that utilizes calcium Ca2+ to activate calmodulin. Activation of
Calmodulin causes Transforming growth factor beta-activated kinase 1 (TAK1) to
activate Nemo Like Kinase (NLK) which inhibits target genes. (iii) In Planar cell polarity,
when Frizzled is activated by the Wnt ligand it binds to intracellular protein, Disheveled
(Dvl) which recruits and activates Daam1. Daam1 then activates RhoA which through
Rho-associated kinases (ROCK) manipulates and rearranges the cytoskeleton (a).
Notch signaling has a membrane-bound ligand and receptor that must interact for proper
cleavage of the receptor (b). The Notch receptor is enzymatically cut in the Golgi
apparatus (S1 Cleavage), this is necessary for the Notch receptor to be activated. Once
the Notch ligand binds to the Notch receptor, the ADAM (a disintegrin and
metalloprotease domain) proteins cleave the extracellular matrix of the Notch receptor
(S2 cleavage). This allows for the g-secretase complex to cleave the transmembrane
domain (S3 cleavage) generating the Notch Intracellular Domain (NICD). The NICD is
translocated to the nucleus where it interacts with TCF/Lef family members to increase
transcription of Notch downstream targets (b). Wnt signaling has been shown to be
manipulated by the tumor suppressor Merlin in different contexts (c). One example is
Merlin has been found to inhibit canonical Wnt signaling within Schwannoma cell lines.
Kim et al. showed that unphosphorylated Merlin inhibits the ability of Frizzled and LRP6
to interact while phosphorylated Merlin no longer binds LRP6 allowing it to interact with
Frizzled (i)(52). Merlin blocks FOXM1 (forkhead box protein M1) from Wnt signaling in
pancreatic cancer cell lines(53). Loss of Merlin stabilizes FOXM1 protein and increases
the amount of FOXM1 that can increase canonical Wnt signaling (ii)(53).The Hippo
signaling pathway is active when YAP/TAZ (Yes associated protein/Transcriptional
coactivator with a PDZ-binding domain) are not active (translocated to the nucleus and
increasing target transcription) (d). Merlin activates the MST1/2 (mammalian ste20
homologs 1/2), Sav (Salvador), MOBKL A/B (Mps one binder kinase activator-like A/B),
and Lats1/2 (Large tumor suppressor 1/2) group of proteins which inhibit YAP/TAZ
nuclear translocation by phosphorylation (d)(54). Targets of YAP/TAZ include BIRC3
and CTGF (d).
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development are utilized more in planar cell polarity (PCP), however whether
ligands are canonical or non-canonical is tissue specific. The Lpt mouse, is a
PCP mutant mouse model that does form endometrial glands, suggesting that
PCP is not necessary for proper endometrial adenogenesis(28).
Apicobasal polarity has also been shown to be important in Wnt signaling.
In Drosophila, Wnt forms a gradient with a majority of the dWnt localizing to the
apical membrane. Interestingly, if dWnt is mutated, basally localized dWnt does
not rescue the phenotype(55). Also, proper localization of the Frizzled receptor to
the apical or basal membrane was shown to determine whether the receptor
activated canonical Wnt signaling or planar cell polarity(56). Understanding the
role apicobasal polarity plays in Wnt signaling may contribute to understanding
the role of Wnt in endometrial development and homeostasis.
Curiously, a constitutively active b-catenin mouse model (Ctnnb1f(ex3)/+;
PR- Cre), exhibits endometrial gland hyperplasia(46). The endometrial gland is
hypothesized to be where endometrial cancer originates. Thus, the phenotype in
Ctnnb1f(ex3)/+; PR- Cre mouse models may represent an early form of endometrial
cancer. In fact, a recent study showed that b-catenin mutations in low-grade and
early stage endometrial cancer patients correlated with an increased risk for
recurrence and metastasis. This is fascinating because this is a population of
patients that have a low risk of recurrence(57). This implies that Wnt signaling is
critical within the uterus and an important factor to consider in endometrial
cancer.
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Canonical
Gene Name Pathway
Located in Endometrium?

Reference

Notch
Notch
Notch

Medium mRNA and low protein diffuse
in tissue
Low mRNA levels
Low mRNA levels

(58)
(59)
(58)

Notch

Low mRNA and medium protein in
tissue

(58)

p21
Axin2

Notch
Wnt

Medium RNA and medium protein in
glands
Medium protein levels in glands

(60)
(61)

c-Myc
Sox9

Wnt
Wnt

Medium protein levels in glands;
mutant mice have decreased fertility
High protein levels in glands

(62)
(63)

HEYL
HES1
HEY1
HEY2

Ccnd1
Wnt
Low protein levels in glands
Table 2 Downstream Targets of Notch and Wnt Signaling

(64)

*This is not a comprehensive list just those examined within this study.
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1.4 Endometrial Cancer
Endometrial cancer is the fourth most common female cancer within the
United States and the fifth most common in the world(65, 66). The highest
incidences of endometrial cancer are observed in the United States, Canada,
and Europe. There are an estimated 10,920 American deaths attributed to
endometrial cancer, making it the sixth most deadly female cancer in the US(66).
Unlike most other cancer types, the rate of endometrial cancer incidence is
increasing and is projected to rise to the third most common female cancer in the
United States within the next 25 years(67). In fact, there has been a 2.3% rise in
the rate of endometrial cancer from 2008-2012 with a portion of that increase
coming from premenopausal women and a 2% increase in the number of deaths
related to the disease. There are some disparities within races with endometrial
cancer, for instance while there was an 84% survival rate in Caucasian women
between 2006-2012, black women saw more than a 20% decrease in survival
within the United States. These differences may be caused by disparities in
socioeconomic situations. Approximately 95-98% of all endometrial cancers arise
in epithelial cells of the endometrium. Traditional classification of endometrial
carcinomas is based on clinical and endocrine features as well as
histopathological characteristics. Within the last two decades, molecular
classification has served as an important advancement to further organize these
tumors(68–70).
Pathologically, there are several different histotypes of endometrial
cancer, such as clear cell, serous and endometrioid, the most common histotype
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(~80%). Standard of care for endometrial cancer generally consists of removing
the ovaries (bilateral salppingo-oophorectomy) and a hysterectomy. Depending
on the stage of the disease, lymph nodes may also be removed. Women still in
their reproductive years may retain their ovaries, preventing early menopause.
Surgery is normally followed by adjuvant chemotherapy in cases determined to
have high risk of recurrence by the histology (serous) and in cases where cancer
is discovered in resected lymph nodes or non-uterine sites.
Clinically, the aggressiveness of the disease is determined during surgical
staging and by histological grade. Staging and tumor grade have a fundamental
importance in treatment decisions. The Federation of Gynecology and Obstetrics
(FIGO) staging used by gynecological oncologists world-wide, place endometrial
cancers in one of four stages. Stage I is when the tumor has not spread outside
of the uterus and is separated into two subcategories: tumors that have invaded
50% or less into the myometrium (Stage IA) and tumors that have invaded more
than 50% of the myometrium (Stage IB). Stage II is defined as when the tumor
has spread into the cervix. Stage III is when the tumor has spread from the
endometrium, cervix, and into other parts of the female reproductive tract (FRT)
and/or lymph nodes. Finally, Stage IV is separated into two subcategories: when
the tumor has invaded into the bladder area (Stage IVA) or cells have
metastasized into distant organs or lymph nodes (Stage IVB). Tumor grade
identifies at what level tumor cells resemble normal endometrial epithelium.
Grade 1 is when the endometrial tumor cells are well-differentiated and are
predominantly comprised of glandular growth with 5% or less of abnormal tissue.
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Grade 2 tumors are moderately-differentiated with between 6-50% of the tissue
considered cancerous. Grade 3 tumors are considered poorly-differentiated
tumors, with a majority of the tissue maintaining very little to no recognizable
epithelial growth patterns. Patients having grade 3 endometrioid tumors have a
poor prognosis, similar to non-endometrioid tumors (serous and clear cell).
Endometrial cancers are also classified more broadly to simplify the disease into
two categories, Type I and Type II, based on histology, molecular characteristics,
and clinical diagnosis of the tumors. It should be noted that this simplified
classification is not utilized in the clinic to determine treatment plans. Type I
tumors include grade 1 and grade 2 endometrioid tumors. These tumors are less
likely to metastasize and have a relatively good prognosis. These tumors are
also highly correlated with obesity and excess estrogen. Type I tumors usually
have mutations within the AKT/PI3K pathway. Grade 3 tumors are considered
Type II along with other non-endometrioid cancers. These tumors are seen at an
older age and are more aggressive with a poor prognosis. Type II tumors
frequently have p53 mutations estimated in some studies to be present in 90% of
cases. Type II tumors also have mutations in other genes including E-cadherin
(80-90%), p16 (40%), or Her2 (45-80%) and not always independent of one
another(71). It is commonly thought within the field that Type I and Type II tumors
form independently and do not progress from one type to another. While a
majority of Type I and Type II tumors are separated by specific pathway
mutations, there is some overlap.
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My work focuses on Type I endometrioid tumors where the epithelium is
still identifiable with key epithelial markers. Type I endometrial cancers commonly
have PTEN (Phosphatase and Tensin homolog) inactivation (50-80%),
microsatellite instability (20-45%), K-ras mutations (10-30%), or b-catenin
mutations (20%) though not always separately(57, 71). Since endometrial
hyperplasia has PTEN inactivation in about 50% of cases, it is hypothesized that
Type I tumors may be progression of hyperplasia. There is a small subset of
Type I tumors that have p53 mutations, Her2 overexpression, p16 inactivation, or
E-cadherin alterations(71).
Recently, Notch signaling has also been found to be downregulated in
early stage and low-grade endometrial cancer cases(72, 73). Multiple Notch
receptor activation mouse models have shown that Notch is necessary for proper
FRT development(26, 74). Notch signaling is involved in both endometrial
development and tumorigenesis, however no one has examined how Notch may
be important in uterine homeostasis.

1.5 Notch signaling
Notch signaling consists of a single pass transmembrane receptor that
binds to an adjacent single pass transmembrane ligand. This interaction opens
up the S2 cleavage site that ADAM (A Desintegrin And Metallopeptidease) family
secretases severs (Figure 2b). This is followed by cleavage at two
intramembrane sites (S3) by g-secretase, an enzymatic protein complex,
generating the Notch Intracellular Domain (NICD). It is not clear how NICD
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localizes to the nucleus from the cell membrane but once present at the nucleus,
the NICD is imported into the nucleus via importin a/b1 signaling(75). NICD
interacts with CSL (CBF1, Suppressor of Hairless, Lag-1) to increase
downstream target gene expression (Table 2, Figure 2b)(76). Mammals have
four Notch receptors (Notch1-4) and five canonical Notch ligands (Jag1-2, Deltalike [Dll]1, 3, 4). While there are differences between the intracellular domains of
Notch1-4, data has shown that the intracellular domains are interchangeable(77).
Previous work has demonstrated that overall levels of active NICD determine
how Notch signaling is functioning within the cell(77, 78). Notch signaling has a
wide variety of downstream targets and cellular functions depending on
spatiotemporal context.
Notch signaling is necessary for proper fate determination in the glandular
and luminal epithelium of the stomach in chicken(79). Specifically, overactivation
of Notch signaling promoted glandular epithelium, while inhibition of Notch led to
luminal epithelium within the stomach in chicken(79). A uterine conditional
overactivation of Notch (Rosa26N1ICD/N1ICD; PR-Cre) in mice caused a loss of
endometrial glands as previously discussed(26). Interestingly, while histologically
there are no endometrial glands, glandular specific markers were found to
express throughout the luminal epithelium(26). Given that in the chicken
stomach, overactivation of Notch signaling causes glandular epithelium
differentiation, potentially these mice have no luminal epithelium present and the
entire endometrium is glandular epithelium(26, 79).
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Apicobasal polarity is important for proper Notch signaling. The
apicobasal polarity regulator, Merlin, is necessary for correct localization of the
Notch receptor in Drosophila(80). In addition, Par3, an apicobasal polarity
protein, causes asymmetric localization of Notch signaling in radial glial cells
during asymmetric division(81). In fact, asymmetric divisions, usually governed
by polarity proteins, promotes Notch signaling during epidermal development in
the mouse as well(82). Understanding apicobasal polarity and the role it plays in
cell signaling may help determine how it is involved in endometrial development
and homeostasis.

1.6 Apicobasal Polarity
Each cell in an organism has an intricate spatial patterning of proteins and
organelles within the membrane and cytoplasm. This patterning is necessary for
proper functioning of the cells. The composition of cells and tissues are also
specifically organized at either a tissue or organ level, respectively. For example,
the uterus is organized (from outermost to inner layers) with the smooth muscle
layers surrounding the endometrial stroma with vasculature and glands
intertwined. The stroma encases the highly polarized, simple epithelium that
surrounds the lumen of the uterus.
At a cellular level, apicobasal polarity determines the side of the cell that
faces the extracellular matrix and the membrane that faces into the lumen of the
tissue. Polarity is initially established through external cues in the extracellular
matrix and cell:cell contacts. There are three major complexes necessary for

21

22

Figure 3 Apicobasal Polarity and Cell adhesion.
Within a single epithelial cell, there is a gradient of apicobasal polarity proteins with a
majority of basal polarity proteins localized on the basal membrane (a). The basal
complex is the Scrib/Lgl/Dlg. The majority of apical proteins are localized on the apical
membrane including two apical complexes. The two apical complexes include the
Crb3/Pals1/Patj complex and Par3/aPKC/Par6 complex (a). The Par complex switches
between Par3 and Cdc42 (b). When aPKC/Par6 is in complex within Par3 it causes
proper apical localization but aPKC is inactive(83). When Cdc42 is in complex with
aPKC/Par6, aPKC is active but the complex is more diffuse within the cell(83) (b). The
apical junctions in epithelial cells include the tight junction and the adherens junction (c).
The tight junction consists of transmembrane proteins: occludin, claudin, and JAMs
(junction adhesion molecules). In addition, there are the scaffolding proteins Zonula
Occludens (ZO) 1-3. The adherens junction consists of cadherin (E-cadherin) molecules
that bind extracellularly to other cadherin proteins. The cadherins bind to b-catenin and
a-catenin (c). Proper establishment of apicobasal polarity is intertwined with apical
junction formation (d). When two cells come into contact, primordial adherens junctions
form. Par3 is recruited to the primordial junction, followed by the aPKC/Par6 complex.
Once Par3/Par6/aPKC are recruited to the primordial junction, junctional maturation
occurs forming adherens junctions and tight junctions (d).
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apicobasal polarity establishment: the Par complex, the Crumbs complex, and
the Scribble complex (Figure 3a). These complexes have been found to work in
conjunction with each other to form a protein based gradient in the cell. Specific
apical and basal kinases oppose each other within the complexes to place apical
proteins on the apical perimeter and basal proteins on the basal side(84–87).
The Crumbs complex is localized to the apical tight junctions and was
initially discovered to cause a dispersed epithelial cuticle when disrupted in
Drosophila melanogaster(88). Mammals have three major isoforms of Crumbs
(CRB1-CRB3)(89–91). The CRB3 isoform is in a complex with PALS1 (Protein
associated with Lin-17) and PATJ (PALS-1 associated tight junction protein)
creating the Crumbs polarity complex(90). Crb3 is expressed in many of the
tissues in the human body including in the endometrial glandular epithelium(92,
93). Interestingly, the Crb3-/- mouse does not show apicobasal disruption in any
of the examined epithelial tissues(94). This is vastly different than what is
observed in three-dimensional (3D) cell culture where cells with Crb3 knockdown
are unable to form proper lumens(95, 96). The Crb3-/- mice do show a decrease
in Patj and Pals1 showing that Crb3 is involved in Pals1/Patj expression(94). Patj
knockdown and Crb3 overexpression in epithelial cells also causes defects in
tight junction formation, however, Patj has not been mutated in mice(97–101).
Pals1-/- mice do have a loss of adherens junctions in select epithelium including
neural tube epithelium(102). The role the Crumbs complex plays in cell polarity is
specific to the cell type and relates to the other polarity complexes.
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The Scribble complex localizes to the basal surface, the membrane
touching the extracellular matrix, and is necessary to define the basolateral
membrane(103). The complex contains Scribble, Discs Large (Dlg) and Lethal
Giant Larvae (Lgl) proteins(103, 104). There are four major homologues of Dlg in
mammals (Dlg1-4) and two homologues of Lgl in mammals (Llgl1-2). Tissue
specific knockout of Scribble in the mammary gland disrupts apicobasal polarity
resulting in loss of tissue architecture(105). However, homozygous Scribble
mutants, like the spontaneous circletail (ScribCrc/Crc) mutant, have severe neural
tube closure defects and stereociliary bundle disorganization in the cochlea
similar to Planar Cell Polarity (PCP) mouse mutants(106, 107). Drosophila dlg
mutants have loss of apicobasal polarity of epithelial cells(108). Interestingly,
Dlgh3 mutant (Dlg3tP038A02/Y) mice exhibit low penetrance of embryonic lethality
and mislocalization of aPKC and apical junction markers at E8.5(109). Dlgh2-4
knockout mice are viable and have behavioral defects, similar to humans with
DLG2-4 mutations that have schizophrenia or mental retardation(110–114).
Dlgh1-/- mice have perinatal lethality and urogenital defects as well(115, 116).
Apicobasal polarity has not been examined in depth in the Dlgh1, 2, or 4 null
mice. Llgl1-/- mice die at birth from hydrocephalus and Llgl2-/- mice have placental
development defects(117, 118). Llgl1-/- and Llgl2-/- mice do not exhibit disruption
in apicobasal polarity in the organs examined(117, 118). However, in vitro
studies showed that when Llgl1-2 were knocked down in combination, apicobasal
polarity is disrupted(87). In Drosophila, Lgl regulates Notch intracellular domain
(NICD) through endosomal trafficking where there is an increase in vesicles and
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an upregulation of Notch target genes(119). This is mirrored in Llgl1 depletion in
Zebrafish (Danio rerio) where Notch signaling increases(120). The Scribble
complex is involved in many functions including planar cell polarity, actin
cytoskeleton regulation, and vesicular trafficking(105, 106, 119), but is most
known for the role it plays in apicobasal polarity.
The Scribble complex is involved in apicobasal polarity through an
antagonistic relationship with the Par complex(87). The Par complex is
composed of Par3 (Partitioning defective 3 homolog), aPKC (atypical protein
kinase c), Cdc42 (cell division protein 42 homolog), and Par6 (Partitioning
defective 6 homolog). aPKC phosphorylates Lgl, which prevents apical
localization of Lgl and the entire Scribble complex in the Drosophila
ectoderm(121). In mammalian cell lines, it was shown that Lgl competitively
binds to aPKC in place of Par3 or Cdc42 allowing the phosphorylation of
aPKC(85). When aPKC is at the basolateral membrane this leads to an
overabundance of Lgl binding and an inactivation of the Par complex since
neither Par3 or Cdc42 can bind. aPKC is a Serine/Threonine protein kinase that
is necessary to maintain the antagonistic relationship with the Scribble complex.
The proteins that compose the Par complex are involved in multiple
functions, not just apicobasal polarity. Par3 is a scaffolding protein that has three
PDZ domains that bind proteins including PTEN, cell junction proteins, and Par6.
In addition, Par3 directly interacts with aPKC. Interestingly, aPKC can
phosphorylate Par3 causing dissociation of Par3 from the Par6/aPKC complex.
Par3 binding to aPKC/Par6 is necessary for proper apical localization (Figure
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3b)(83). Cdc42 is in complex with activated aPKC and is thought to be necessary
for activation (Figure 3b)(83).
In epithelial cells, cell polarity proteins act in tandem with specific cell:cell
or cell:matrix complexes. The Par complex is established through cellular contact
(Figure 3d). In cell culture when two cells make contact, the adherens junction
protein, E-cadherin is recruited to the site of contact. This initiates the formation
of primordial apical adherens junctions. Par3 is recruited to the primordial
junction through the tumor suppressor protein Merlin and junctional adhesion
molecules (JAMs)(122, 123). Par6/aPKC subsequently localize to the junction
where Par3 binds to the complex (Figure 3d).
Par3 was initially found in C. elegans in 1988 when Kemphues et al.
showed it was necessary for asymmetric division of the one-cell C. elegans
embryo(124). Par3 has three major isoforms(125). The 180kD and 150kD
isoforms both have the aPKC binding domain, while the 100kD isoform does not
bind to aPKC(125). Since the 100kD isoform does not bind to aPKC it is thought
to not play a role in apicobasal polarity. My dissertation work focuses on the
isoforms that bind aPKC and are involved in apicobasal polarity. Par3 has
multiple functions within the cell including the regulation of primary ciliogenesis,
PI3K/AKT signaling, and apicobasal polarity(124, 126–129). The ability of Par3
to bind to Kif3a, a microtubule motor protein for cilia, is necessary for proper
primary cilia formation in cell culture(126). Par3 also binds PTEN and is required
for proper localization of PTEN in Drosophila and cell culture(130, 131). It was
determined that PTEN also played a role in proper Par3 localization and tight
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junction function, thus both are necessary for proper apical membrane
establishment(127, 131, 132).
Par3 is necessary for the proper establishment of the apical cell
membrane in model organisms and mammalian cell culture(128, 129). Par3 was
found to be critical for correct asymmetric division of radial glial cells into a
daughter radial glial cell and a neuron. This was found to be mediated through
asymmetric division of Notch signaling(81). Studies of the Par3 knockout mouse
(Par3DE3/DE3) showed a failure of epicardial development leading to embryonic
lethality between embryonic day 12.5-14.5 (E12.5-E14.5)(133). The epicardial
progenitors are unable to form cysts that are necessary for proper formation of
the epicardium(133). This inability to bud into cysts is hypothesized to be from
mislocalization of polarity proteins(133). Defective epithelial cyst formation has
also been observed in Par3 knockdown cells(72, 134). Besides aberrant heart
development, the Par3DE3/DE3 mice also exhibit some amount of stunted growth at
E9.5 and a shortened tail(133). It is suggested the reason there are not more
evident issues with other epithelial organs at earlier embryonic stages is because
other proteins like Par3L or Par3b compensate for the loss of Par3. Conditional
Par3 knockout (Par3lox/lox; K14-Cre hereafter referred to as Par3eKO) within the
skin causes an inside-out barrier defect in newborn pups with mislocalization of
tight junction proteins, ZO-1 and claudin-1(135). An inside-out barrier defect is
when the barrier that holds moisture and other substances in the body is
defective, thus a severe barrier defect would cause lethal dehydration. A similar
phenotype is observed in Claudin-1 null mice(136). Except for the mislocalization
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of Claudin-1, the tight junction loss reverts back to wild-type by P58 in Par3eKO
mice(135). This may be attributable to a compensatory mechanism. As the
Par3eKO mice age there is an increase in hypertrophic and multilobular
sebaceous glands(135). In addition, there is an increase in overall epidermal
thickness in Par3eKO mice at birth(135). Further phenotypes related to cancer
have been identified in Par3 knockout mice that will be discussed in 1.7
Apicobasal Polarity in Cancer(137, 138). Par3 has also been found to be critical
in mammary gland development(139). Par3 knockdown caused a 44% decrease
in growth of mammary glands across the fat pad when transplanted compared to
wild-type control cells(139). In addition, the Par3 knockdown glands were
unorganized, multilayered, and small(139). It was found that the aPKC binding
domain of Par3 was necessary to rescue the growth of the mammary gland(139).
Atypical Protein Kinase C (aPKC) is one of three subfamilies of PKCs
(novel PKC and classical PKC) that contains two proteins PKCz and PKCl/i.
aPKC proteins have various roles through tissue development that have been
observed in mouse models. Pkcz null mice are viable but show abnormalities in
the ratio of B:T cells caused by NF-Kb signaling(140). The important role of
aPKC proteins in the immune system was confirmed when both Pkcl/i and Pkcz
affect the ability of T lymphocytes to properly go through asymmetric
division(141). This disruption of asymmetric division is also observed with other
polarity mutants in different cell types(81). Pkcl/i has been implicated in the
development and maintenance of many organs including the kidney and the hair
follicle(142–147). When Pkcl/i is deleted in the developing kidney nephrons
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(aPkcllox/lox; Nphs1-Cre) it causes renal dysfunction by 4 weeks of age leading to
death by about 6 weeks of age. The renal dysfunction is due to mislocalization of
nephrin and podicin proteins which are necessary for proper formation of the
podocyte tight junction(145), similar to polarity proteins in other epithelium. Loss
of Pkcl in the epidermis (aPkcllox/lox; K5-Cre) causes progressive hair loss due to
a slow regression of the bulge stem cell niche through an increase in asymmetric
cell divisions and a decrease in symmetric cell divisions(147).
While Par6 has not been thoroughly studied in vivo, there is a
Par6a mutant (PARD6atm1.1(KOMP)Vlcg/tm1.1(KOMP)Vlcg) generated by the International
Knockout Mouse Consortium with a few noted phenotypes including changes in
T-cell numbers, aberrant bone mineral content and changes in body fat(148).
There has been some work that links Par6 to cancer. Par6 was found to promote
proliferation of breast cancer cells and epithelial-mesenchymal transition (EMT)
through TGFb in non-small-cell lung cancer (NSCLC) cell lines(149, 150). High
levels of Par6 have also been correlated with aggressive prostate cancers and
EMT in breast cancer indicating the Par complex may be involved and promote
tumorigenesis.

1.7 Apicobasal Polarity in Cancer
Apicobasal polarity is a characteristic of all epithelial tissues. A majority of
solid tumors lose apicobasal polarity, however in the past it was thought to be a
secondary effect of the driver mutations and cancer hallmarks, such as EMT that
are necessary for cancer metastasis(151). Recently, evidence has been
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mounting that implicates a major role of polarity in the progression of cancers
(Table 3). The Crumbs3 protein from the Crumbs complex has been shown to
suppress features of tumorigenesis (metastasis, pluripotency) in normal kidney
and breast cell lines(152, 153). The Scribble complex proteins, Scribble and Dlg,
are targeted by the Human Papillomavirus (HPV) for degradation and this
decrease of protein at the membrane is correlated with higher grade and more
invasive cervical malignancies(154–156). Scribble deficiency in mice predisposes
them to prostate cancer(157). Interestingly, Scribble is mislocalized in prostate
cancer and basal breast cancer patients and correlate with a poor prognosis(157,
158). While there are some excellent reviews on both the involvement of the
Crumbs and Scribble complexes in cancer(159, 160), my dissertation work
focuses on the Par complex.
The Par complex has been found to be lost in a variety of cancers
including breast, colon, and gastric cancer(92, 93, 161). Par6 has been shown to
be necessary for EMT in a breast cancer cell line when TGFb (transforming
growth factor b) signaling is disrupted however no in vivo studies have confirmed
this(149). There is a decrease in Par6 protein levels in stomach and colon
cancer however this has not been examined in detail(92, 93). Pkcz has been
found to act as a tumor suppressor while Pkci acts as an oncogene in some
mouse models. Pkcz-/- lungs that were stimulated by the oncogene, Ras, had a
20% increase in tumor burden compared to wild-type Ras-stimulated
lungs(162). Galvez et al. determined that Pkcz suppresses Interleukin-6
(IL6)(162), an inflammatory signal that is increased in cancer patients(163).
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Experimental
Gene (Protein)

Crb3 (Crumbs3)

Dlg1 (Dlg1)

Dlg2 (Dlg2)

Dlg3 (Dlg3)

Dlg4 (Dlg4)

Dlg5 (Dlg5)

Llgl1 (Lgl1)

Uterine Phenotype Cancer-related Data Human Cancer Data
Loss contributes to
Amplification in sarcoma,
tumorigenesis;
neuroendocrine prostate, breast
targeted by viral
cancer, paraganglioma; deletion
oncoproteins for
in uterine, stomach and lung
Not known
degradation
adenocarcinoma
Directly interacts with
APC and PTEN; with
Dlg3 and Dlg4
interacts with
oncoprotein Net1;
Absent vagina, No DLG paralogs targeted
lateral fusion of the by human virus
Dlg1 somatic mutations in breast
Mullerian ducts
oncoproteins;
cancer

References

(152, 164–
166)

(116, 166–
168)

Not known

Not known

Amplification in breast, prostate,
ovarian, and lung cancer;
mutations in melanoma, uterine,
stomach, lung, stomach,
colorectal, cholangiocarcinoma,
bladder cancer
(164, 165)

Not known

Associates with APC;
cancer cell lines
overexpression results
in suppression of cell
growth, cell migration,
and invasion; interacts
with oncoprotein Net1

Dlg3 is downregulated in gastric,
esophageal, and glioblastoma;
upregulated in serous ovarian
carcinoma and breast cancer
(169–171)

Not known

Interacts with
oncoprotein Net1;
Deletion in prostate, pancreas,
degradation of Dlg4 by bladder, liver, colon, and
HPV
lymphoma

(164, 165,
171, 172)

Not known

Loss induces breast
cancer cell migration
and disruption of
apicobasal polarity;
Loss shows increases
in Hippo signaling in
breast cell lines

Genetic variant (R30Q)
associated with inflammatory
bowel disease and Crohn's
disease; Dlg5 loss in prostate
cancer; Dlg5 upregulated in
gastric and pancreatic cancers

(164, 165,
173–175)

Lgl1 KO mice have
brain dysplasia and
invasion

Loss of copy number correlates
GBM poor survival;
lost/downregulated in melanoma, (117, 164,
prostate, breast, and colon
165,
cancers; Lgl1 loss correlates with 169)(117)

Not known
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advanced staging of colorectal
cancer and melanoma

Llgl2 (Lgl2)

Mpp5 (Pals1)

Pard3 (Par3)

Not known

Decreased
expression/mislocalization in
Mutations in zebrafish gastric cancers; low levels
causes epidermal
correlated with colorectal cancer (169, 176,
hyperproliferation
aggressiveness
177)

Not known

Pals1 is necessary for
cerebellar progenitor
cell proliferation;
Important for Ecadherin membrane
trafficking in MDCK
cells

Not known

Downregulated in breast cancer
and improper localization in
metastatic disease; proper
Par3 KO in skin delays localization decreased in
Ras-induced
metastatic disease;
papillomas but
Downregulated in ESCC &
predisposes skin to
correlated with metastasis;
keratoacanthoma;
Deletion in HNSCC and
Par3 KD increases
glioblastoma; Upregulated and
metastasis in breast associated with poor prognosis in (137, 180–
cancer
hepatocellular carcinoma
183)

Mutations in bladder, uterine,
cholangiocarcinoma, colorectal,
adenoid cystic carcinoma,
melanoma; amplification of
prostate esophagus, stomach,
head & neck, ovarian, and
sarcoma; deletions in adenoid
cystic carcinoma

(164, 165,
178, 179)

Pard6a/Pard6b/Pard6g
(Par6)
Not known

Par6 promoted
proliferation of breast
cancer cells;
Establishes front to
rear polarity;
necessary for cancer
cell invasion and
cell:cell adhesion;
Par6 phosphorylation
induces E-cadherin
reduction and TGFb
EMT in NSCLC cells

Par6 thought to be protumorigenic in breast cancer;
Par6b upregulated in breast
cancer and associated with EMT
characteristics; high Par6 in
stromal cells correlates with
better prognosis in NSCLC; high
levels correlated with aggressive (149, 150,
prostate cancers
164, 165)

Patj (Patj)

Not known

Targeted by viral
oncoproteins for
degradation

Mutations in melanoma, lung
adenocarcinoma, head & neck
cancer, cholangiocarcinoma

Not known

Promotes breast
cancer cell metastasis;
promotes tumor
Upregulated in NSCLC, colon
growth for
cancer, ovarian cancer,
glioblastoma cells;
esophageal squamous cell
promotes
carcinoma (ESCC), breast
Cholangiocarcinoma cancer, hepatocellular
cell migration,
carcinoma, basal cell skin
metastasis and
cancer; correlated with poor
proliferation
survival in patients

PRKCI (PKCi)

(164–166)

(164, 165,
184–187)
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Suppresses IL6
decreasing cell
proliferation in lung
cancer model

PRKCZ (PKCz)

Not known

PTEN (PTEN)

PTEN mice have
endometrial
neoplasia;
Conditional PTEN
knockout in the
-/+
endometrium
PTEN mice have
causes endometrial neoplasia in many
cancer
organs

Higher levels of PRCKZ or
PRCKI correlate with delayed
tumor recurrence in bladder
cancer; Upregulated in
hepatocellular carcinoma
prostate cancer, bladder
transition cell carcinoma,
pancreatic ductal cancer, head
and neck squamous cell
carcinoma, and breast cancer;
Correlates with poor survival in
patients with non-GIST STSs;
May play a role in breast cancer
metastasis; Higher levels
correlates with a better prognosis (162, 164,
in colorectal cancer patients
165, 185)

-/+

Scrib (Scribble)

Stk11 (Par4/Lkbi)

(164, 165,
Commonly lost tumor suppressor 188)

Loss promotes
prostate and lung
Reduced Scribble correlates with
cancer formation &
invasiveness in cervical cancer;
progression; increased increased Scribble increases;
Scribble increases
tumor suppressor in human
AKT signaling in
cancers; amplified in many
(105, 164,
Not known
breast cancer models human cancers
165)
LKB1 deficiency
promotes breast
cancer cell invasion;
-/+
LKB1 loss activates
LKB1 mice
develop
TGF-b signaling
endometrial
angiogenesis; Loss of
adenocarcinomas; LKB1 expression and
Conditional deletion K-Ras activation
of LKB1 in the
resulted in melanoma Implications in NSCLC, ovarian,
uterus caused
formation; LKB1 loss uterine; amplified in pancreatic,
completion
increases CSCs; LKB1 NEPC, sarcoma,
transformation of
tumor suppressor
cholangiocarcinoma, ACC, MBL,
the endometrium
gene mutations cause Glioma, and GBM; mutated in
and highly invasive autosomal dominant lung, LUAD, cholangiocarcinoma,
and deadly
condition, Peutzesophagus, bladder, HNC,
(164, 165,
endometrial cancer Jeghers
pancreas, and stomach
188–190)

Table 3 Involvement of Cell Polarity Proteins in Cancer and the Uterus
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Par3 suppresses breast tumorigenesis through aPKC(138, 185). When
Par3 is depleted in vivo with a mutated oncogene, such as Notch or Ras6IL, there
is an increase in metastatic disease caused by an increase in matrix
metalloproteinase 9 (MMP9) which is important for degrading the extracellular
matrix (ECM)(138). MMP expression has been associated with increased
migration and invasion. MMP9 was upregulated through an increase in IL6
production stimulating Stat3 (Signal Transducer and Activator of Transcription 3)
signaling(138). This was found to be caused by an overactivation of Pkci that is
normally controlled by Par3(185). Similarly in skin, Par3 loss (Par3eKO) caused
a 70% increase in the number of mice with keratoacanthoma, a relatively rare
tumor in mice(137). Intriguingly, in oncogenic Ras skin cancer mouse models,
Par3eKO caused a delay in papilloma development and a reduction in tumor
growth but caused a 12% increase in metastasis of the tumors that were
observed(137). Since papilloma tumors originate from oncogenic Ras expression
in keratinocytes while keratoacanthomas are thought to come from the basal and
suprabasal layers of the epidermis, this study may show a tissue specific function
of Par3 as either an oncogene or a tumor suppressor(137). In both cases, loss of
Par3 seemed to stimulate invasion or migration of the cancer cells(137). In
addition, clear cell renal cell carcinomas with overexpression of Par3 have been
correlated with a lower survival rate, insinuating that Par3 may be an oncogene
in renal carcinomas(191). Par3 has been directly tied to tumor progression which
may be because Par3 interacts with many known tumor suppressors, such as
PTEN (Phosphatase and Tensin homolog), as well as oncogenes(192, 193).
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PTEN is most well-known for blocking PI3K (Phosphoinositide 3-Kinase)
signaling by converting PIP3 (Phosphatidylinositol (3,4,5)-triphosphate) to PIP2
(Phosphatidylinositol (3,4,5)-diphosphate). PIP3 is necessary for proper
phosphorylation of AKT (Protein Kinase B), which leads to activation of the PI3K
pathway. PTEN is a tumor suppressor that is deleted or mutated in a large
number of cancer types including glioblastomas, breast, prostate, and
endometrial(194–196). PTEN is also involved in cell polarity through the Par
complex. A few studies have shown that PTEN and Par3 bind to each other and
that PTEN can affect proper polarization of mammalian epithelium(130, 131).
About 43% of all endometrial malignancies have PTEN mutations with more than
50% of the epithelial-specific tumors being mutated(196). Surprisingly though,
64% of all endometrial malignancies (75% of epithelial tumors) have PTEN
protein loss indicating control of PTEN could be through post-translational
mechanisms(196). While PTEN is mutated in a majority of endometrial cancer
cases, polarity has not been thoroughly examined within the endometrium.

1.8 Apicobasal Polarity in the Endometrium
The dynamic nature of the endometrium along with the two forms of
tubulogenesis (Mullerian duct and endometrial gland), that occurs in uterine
development imply that cell polarity is highly regulated within the endometrium.
While, apicobasal polarity has not been examined in cycling mice, glycoproteins
like Muc1 have been examined in great detail. Muc1 and other mucins are found
at only the apical lumen of the luminal and glandular epithelium(197). This
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insinuates some level of apicobasal polarity within the endometrial epithelium.
During the estrous cycle, Muc1 heavily stains the apical lumen at the highest
points of estrogen (estrus and proestrus) while the diestrus and metestrus stages
have decreased staining corresponding with high levels of progesterone(197). It
appears that proestrus has the most discrete apically localized Muc1(197). Since
proestrus and estrus represent the most differentiated state, we can postulate
that these states are when apicobasal polarity and cell adhesion are fully
established. In addition, endometrial integrins are upregulated during the
menstrual cycle in humans, where different phases show differing levels of
integrins(198). This may suggest that different phases of the menstrual cycle
require a more polarized endometrial epithelium. Since the endometrium is being
shed (and reabsorbed during estrous), this may be from the reorganization of the
polarity and adhesion complexes. Interestingly, integrins and Muc1 change
expression and localization during blastocyst implantation as well(197).
Implantation is where a majority of polarity related studies have been performed
in the uterus. In general, to increase uterine receptivity there is a reduction in
glycoproteins. This reduction in glycoproteins along with an increase in select
integrins show that polarity is dynamically regulated within the
endometrium(199).
Disrupting homeostasis in the endometrium is known for causing diseases
like endometriosis or endometrial cancer. Homeostasis can be affected by
disruptions in polarity or polarity regulating proteins like Ezrin(200). Ezrin is an
ERM (Ezrin-Radixin-Moesin) family member that marks the apical surface and is
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involved in cortical actin stability(201). An increase in Ezrin expression is
observed in endometriosis, a disease in which endometrial tissue grows in
aberrant locations throughout the body, including the ovaries, oviducts, and lining
of the pelvis(202).
While no one has looked in depth at how apicobasal polarity affects
endometrial gland development, DLGH1-/- mice were found to have aberrant
Mullerian duct development that caused a loss of vaginal tissue and an
endometrium that is more caudal within the uterus(116). Unfortunately, postnatal
development of the uterus has not been examined in these mice. Scribble, the
basal polarity protein, has also been shown to affect Mullerian duct formation
including a loss of Sox9 expression and thinning of the Mullerian duct compared
to wild-type mice at E13.5(157). A planar cell polarity protein, Vangl2, can also
affect the localization of Scribble within the FRT(107). Planar cell polarity is the
organization of specialized apical structures on cells across the tissue. The
Vangl2lp mouse exhibits both a mislocalization of Scribble from the basolateral
membrane but also shortened uterine horns(28). Interestingly, mice
heterozygous for Vangl2lp generate a significantly reduced number of glands(28).
Many of the secreted Wnt proteins that cause aglandular phenotypes when
mutated are thought to be involved in planar cell polarity as well as canonical
Wnt signaling. These studies with the Vangl2lp PCP mutant mice show that not all
planar cell polarity proteins are involved in gland development similar to
Wnt7a(35).
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Since cell adhesion and cell polarity are intertwined analyzing the data
from conditional deletion of cell adhesion genes in the uterus may hint at how
apicobasal will affect endometrial gland development. When E-cadherin
(Cdh1lox/lox; PR-Cre) or b-catenin (Ctnnb1lox/lox; PR-Cre), adherens junction
proteins, are deleted in the mouse endometrium, an aglandular phenotype is
observed(45, 46). However, in E-cadherin null endometrium, the luminal
epithelium also looks abnormal and no longer is positive for the common luminal
epithelium marker, cytokeratin 8(45). This suggests the possibility that glands are
unable to form because the precursor luminal epithelium does not develop
properly(45). In addition, the aglandular phenotype observed in b-catenin null
mice suggests it is more likely canonical Wnt signaling that drives the aglandular
phenotype(46). Understanding how cell adhesion and cell polarity are involved in
endometrial development may aid us in determining how the different signaling
pathways are utilized.

1.9 Cell Adhesion
Every tissue in the body utilizes cell adhesion in order to properly function and
communicate with the neighboring cells and environment. Cell adhesion is
especially well characterized in epithelium, however, it has also been examined
in cardiomyocytes, endothelial, and Schwann cells(203–205). Epithelial cells
have junctions at the interface with the extracellular matrix (ECM) and between
neighboring cells. The adhesions that anchor the cell to the ECM include the
focal adhesions and the hemidesmosomes. Focal adhesions are regulated by
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Rho activity and contain numerous proteins including Focal Adhesion Kinase
(FAK) and Vinculin(206, 207). Hemidesmosomes mediate the attachment of
intermediate filaments to the cell membrane and are attached to the ECM
through integrins. Hemidesmosomes are found in a selective number of tissues,
specifically epithelial tissues, such as the mammary gland or skin.
On the lateral cell membrane, there are cellular junctions that attach the
epithelial cells together. This includes tight junctions and adherens junctions in
the apical domain as well as desmosomes. The desmosomes are similar to
hemidesmosomes in that they anchor intracellular intermediate filaments to the
membrane, however the proteins that compose the junctions are different.
Desmosomes are made of desmogleins, desmocollins, and desmoplakins, while
hemidesmosomes are composed of integrins(208). The adherens junction
utilizes two cadherin molecules, one anchored to each cell, that can have either
homophilic or heterophilic adhesion in the extracellular domain. b-catenin and
p120 bind directly to the cadherins. b-catenin binding is necessary for proper
actin binding through a-catenin. These junctions are necessary for the initial
cell:cell contact and play a role in stabilizing junctions (Figure 3d). There is a
hierarchy to junction formation. Initially, adherens junctions are formed at the
point of contact, then desmosomes, and finally tight junctions. Issues with proper
ordering of junctions has been associated with different diseases like
inflammatory bowel disease (IBD)(209–211). In addition, there is some evidence
that adherens junctions have a role in different signaling pathways, which may
contribute to diseases like IBD. The tight junctions are electrically resistant
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junctions and necessary for proper barrier formation in most epithelium. Tight
junctions are composed of multiple transmembrane and scaffolding proteins
including claudins, occludin, and the zonula occludens (ZO) 1-3.
My work focuses on the apical junctions consisting of adherens junctions and
tight junctions (Figure 3c). The apical junctions form as the epithelial cells
organize and differentiate. Junctional maturation will then occur when the tight
and adherens junction proteins form discrete and functional junctions (Figure 3d).
These junctions are necessary for organs to properly work. Deletion of numerous
genes encoding tight junction proteins exhibit surprising phenotypes. For
example, ZO-1 deficiency is embryonic lethal for mice by E11.5 and was shown
to have an angiogenesis defect that leads to an immature yolk sac(212).
Interestingly, when ZO-1 is lost in the renal podocytes (Tjp1lox/lox, Nphs1-Cre)
similar to the aPKC mutant mouse, podocyte tight junctions were unable to form
properly(145, 213). Occludin null mice have normal tight junctions in both
structure and function in the kidney. Thus we can conclude that Occludin (gene:
OCLN) is not required for proper tight junction function in the kidney(214). OCLN/-

mice do exhibit aberrant branching of the gastric glands and male mutants were

infertile(214). Interestingly, female Occludin null mice were fertile but could not
suckle their pups(214). Claudins (gene: CLDN) are necessary for proper tight
junction formation and when specific Claudins are overexpressed in fibroblasts,
cells that normally do not have tight junctions, they form tight junction-like
structures. CLDN11-/- mice no longer have tight junctions in multiple tissues,
remarkably these mice are still viable(215). Similar to OCLN-/- mice the CLDN11-/-
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males are sterile but the females breed similar to wild-type mice(215). CLDN1-/mice have an inside-out barrier defect in the epidermis similar to the Par3eKO
mice(135, 136).
Adherens junction proteins have been examined a with uterine specific Cre. A
conditional b-catenin knockout mouse (Ctnnb1lox/lox; PR-Cre) has an endometrial
aglandular phenotype that was previously discussed in section 1.8 Apicobasal
Polarity in the Endometrium. Ctnnb1-/- mice are embryonic lethal during
gastrulation where the ectodermal cell layer is unable to develop(216). Cdh1-/mice are also embryonic lethal due to an inability to form a trophectodermal
epithelium(217). In addition, a mutation in E-cadherin that disrupts Ca2+ binding
(Cdh1tm1Cbm/tm1Cbm) are embryonic lethal at a similar stage as the Cdh1-/-,
potentially showing the lethality is due to loss of adherens junctions(218).
Conditional loss of E-cadherin in the uterus (Cdh1lox/lox; PR-Cre) causes an
aglandular phenotype that was previously mentioned in section 1.8 Apicobasal
Polarity in the Endometrium(45). Cdh1lox/lox; PR-Cre mice do not show
histological signs of columnar epithelium by P10(45). In addition, these mutants
showed a loss of b-catenin, a-catenin, and tight junction proteins(45). This loss of
normal adhesion structures within the epithelium is hypothesized to be the cause
of the abnormal epithelial architecture(45). The inherent connection between cell
polarity and cell:cell adhesion in regulating uterine development and disease
would indicate that how this connection is modulated would be important in the
uterus. Curiously, female mice heterozygous for the tumor suppressor Merlin,
which has been shown to coordinate apicobasal polarity and adhesion, have
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small litters, but why these mice have reduced litter sizes is not known(219).
Understanding the role of Merlin in the uterus will help to comprehend how
polarity and adhesion coordinate regulation of uterine homeostasis.

1.10 Merlin
Merlin is a tumor suppressor protein that was originally discovered as the
gene (NF2) mutated in Neurofibromatosis Type 2(220, 221). Merlin is a
scaffolding protein that links a multitude of other proteins causing it to have a
wide-variety of functions (Table 4). It is well known for being a negative regulator
of Hippo signaling in the mammalian brain and liver (Figure 2d)(222, 223). In
addition, Merlin is necessary for proper junctional maturation and apicobasal
polarity establishment in epithelial tissues(122). Merlin is a member of the EzrinRadixin-Moesin (ERM) family, but unlike the other ERM family members, Merlin
is missing the C-terminal actin binding site. Ezrin, Radixin, and Moesin are
hypothesized to have overlapping functions in different epithelial tissues.
However, Merlin has been shown to have distinct roles. While initially discovered
in NF2-associated central nervous system tumors, Merlin has been found to
affect the development and homeostasis of different mammalian epithelial
tissues(122, 224, 225). Merlin has a such a wide-variety of functions (Table 4), it
is pertinent to understand how it affects the female uteri.
Nf2-/- mice are embryonic lethal by E8.0 because they are unable to
induce mesodermal differentiation during gastrulation(226). In addition,
conditionally knocking out Merlin in specific tissues causes aberrant tissue
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Phenotype

Model

Reference

Hyperproliferation of the eye epithelial cells

Drosophila Mer

(227)

Embryonic lethality caused by loss of extraembryonic
structures

Mouse Model (Nf2-/-) (226)

Increased metastatic disease; Decreased female fertility
Loss of contact inhibition and mislocalization of b-catenin;
Unstable adherens junctions; increased pEGFR; inability for
Merlin to associate with EGFR through NHE-RF1 (normally
confluency dependent)
Both: Loss of sperm; Testicular atrophy; Increase in
Lymphomas, chronic hepatitis, and invasive kidney
adenocarcinoma; Nf2-isoform 2-/- specifically caused delayed
sensory reactions, signs of axonal neuropathy, irregularly
shaped axons
Increased internalization of EGFR at confluence; Increased
mechanical tension and myosin II activity

Mouse Model (Nf2-/+) (219)

Nf2-/- MEFs

(228, 229)

Mouse models
Nf2-isoform 1-/-; Nf2isoform 2-/(230, 231)
Liver-derived
epithelial cells from
Nf2-/- livers; Caco2
cells with shNf2
(232)

Expansion of liver progenitor cells; increased risk of
cholangiocellular & hepatocellular carcinoma
Fiber cells overproliferate and do not differentiate properly;
Mislocalization of ZO-1; Multilayering of lens cells with an
extracellular matrix.

Mouse Model
(Nf2lox/lox; Alb-Cre)

(224)

Mouse Model
(Nf2lox/lox; Le-Cre)

(233)

Decrease in nerve regeneration; Delayed motor and sensory
recovery

Mouse Model
(Nf2lox/lox; Nefh-Cre)

(234)

Schwann cell hyperplasia and tumors; cataracts and cerebral
calcifications

Mouse Model
(Nf2lox/lox; PO-Cre)

(235)

Schwann cell hyperplasia and tumors; cataracts and cerebral
calcifications
Renal intratubular neoplasia at 3 months, hyperproliferative
and invasive renal carcinoma by 10 months induced by
aberrant EGFR signaling, inability to stabilize apical junctions

Mouse Model (P0Sch-D(39-121),
overexpression)
Mouse Model
(Nf2lox/lox; Vil-Cre)
(Nf2lox/lox; Mx1-Cre)

Required for proper apical junction maturation; Necessary for
proper apicobasal polarity establishment; Inside-out barrier
defect; Disorganization and stratification defects of epidermis

Mislocalization of Ezrin; misoriented spindles; Multi-lumen 3D
cultures; aberrant centrosome localization

(236)
(225)

Mouse Model and
Primary
Keratinocytes
(Nf2lox/lox; K14-Cre)
(122)
shRNA-Nf2 in Caco2
cells; Mouse models
(Nf2lox/lox; K14-Cre,
Nf2lox/lox; VilCreERT2,
(237)
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Loss of hair follicle planar cell polarity; Improper development
of the bulge stem cell; Decrease in Sox9 expression

Mouse Model
(Nf2lox/lox; K14-Cre)

(238)

Table 4 Functions of Merlin in different tissues
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morphogenesis and homeostasis. In the liver, when Merlin is lost (Nf2lox/lox; AlbCre hereafter referred to as Nf2LKO), it causes an overgrowth of the liver oval
cells (OCs), without causing any phenotypes in the hepatocytes and this was
shown to be caused by an overactivation of EGFR signaling(224). Nf2LKO mice
also exhibit hepatocellular carcinoma and cholangiocarcinoma if they survive to
adulthood(224). Interestingly, while OCs were determined to be the source of the
tumors, different labs observe EGFR or Hippo signaling as the main cause of
tumorigenesis(223, 224). The tumorigenic properties of Merlin have been
observed in other mutants as well. Nf2+/- mice have a high frequency of
osteosarcomas as well as a higher number of hepatocellular carcinomas that
metastasize(219). This was different than humans, who are hemizygous for Nf2,
that commonly get vestibular schwannomas(239). Merlin loss in the kidney
(Nf2lox/lox; Vil-Cre) causes invasive renal carcinomas by 6 months of age(225).
These tumors had a decrease in junction and polarity markers similar to affects
observed in the skin(122, 225). In the skin, Merlin was determined to be
necessary for proper recruitment of Par3 to the primitive apical junction before
junctional maturation(122). Loss of Merlin in the basal cells of the epidermis
(Nf2lox/lox; K14-Cre hereafter referred to as Nf2skinKO) causes an inside-out
barrier defect like other cell adhesion and polarity mutant mice(122, 135, 136).
Nf2skinKO mice also exhibit abnormal skin morphology from aberrant
asymmetric divisions of the basal cells(122). Merlin deficiency in Schwann cells
produces a loss of contact inhibition which is instigated by increases in canonical
Wnt signaling(240). Merlin inhibition of canonical Wnt signaling is also observed
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in pancreatic cancer cell lines(53). However, it appears that how Merlin affects
Wnt signaling is tissue dependent (Figure 2c)(53, 241–243). Merlin is involved in
many signaling pathways because of the proteins it is able to bind to and
indirectly regulate. A Merlin binding partner, NHE-RF (Na+/H+ Exchanger
Regulatory Factor), is found to localize to the apical lumen of the endometrium at
specific times during the menstrual cycle and is hypothesized to be important in
estrogen signaling and proliferation(244). Merlin has been found to affect the
localization of the membrane-bound receptor, Notch, in Drosophila(80). In
addition, Notch signaling has been shown to be regulated during the menstrual
cycle(245). Merlin may play an important role in endometrial development and
homeostasis through the different proteins and pathways it interacts with(80, 122,
246, 247).

1.11 Dissertation Summary
This dissertation examines how Merlin and apicobasal polarity affect
endometrial development and endometrial cancer. We find that Merlin is
necessary for proper endometrial gland formation. In addition, Merlin may be
important in Mullerian duct polarized migration. We determined that conditional
loss of Merlin within the endometrium causes a mislocalization of polarity
proteins and infertility through changes in F-actin that may facilitate the decrease
observed in Wnt signaling. Furthermore, Merlin is necessary for proper
endometrial homeostasis during aging. In addition, we have established that
apicobasal polarity is lost in endometrial cancer and polarity loss causes changes
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in compartmentalization of the membrane-receptor, Notch. Finally, we observed
that Notch signaling plays a role in polarity induced proliferation and migration
changes in endometrial cancer cell lines.
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Chapter 2: Materials & Methods
This chapter is modified from Williams, E., Villar-Prados, A., Broaddus, R.,
Gladden, A. (2017) Loss of polarity alters proliferation and differentiation in lowgrade endometrial cancers by disrupting Notch signaling. PLoS ONE 12 (12):
e0189081. https://doi.org/ 10.1371/journal.pone.0189081 is licensed under CC
BY (Creative Commons Attribution license) by PLoS One.

2.1 Mouse Strains
We generated both the Nf2lox/lox; Wnt7a-Cre and the Nf2lox/lox; PR-Cre
mouse lines by crossing the previously generated Nf2lox/lox mice with either
Wnt7a-Cre mice or PR-Cre mice(248–250). When crossing, Cre was paternally
contributed and control mice were either Nf2lox/lox, Nf2lox/wt; -Cre as heterozygous
deletion showed no phenotype in the uterus. Mice were maintained on a mixed
FVB, C57BL/6 background. The MD Anderson Cancer Center Institutional
Animal Care and Use Committee (IACUC) approved all animal procedures. Mice
were bred to generate homozygous female mutants.
2.11 Fecundity Study
Six wild-type (Nf2lox/lox, Nf2lox/wt; PR-Cre, Nf2lox/wt; Wnt7a-Cre) and 6
Nf2lox/lox; PR-Cre mice were mated for 3 months. Mice were examined for plugs
every morning. After mice were plugged, weight was taken at E0.5 and then
again at E7.5 until mice were at E14.5. Nf2lox/lox; PR-Cre mice did plug but did not
gain weight while wild-type mice would start to increase in weight around E7.5.
Females were left with males during the entire 3 months and litters were counted
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for number of pups. 3.5 DPC uteri were obtained from mice, 3 days after vaginal
plugs were observed.

2.2 Immunohistochemistry
Use of human tissues was approved by the IRB of the University of Texas
MD Anderson Cancer Center (LAB1-718) (PI: Broaddus). Informed written
consent was obtained through the MD Anderson Cancer Center “Front Door”
tissue banking consent policy (LAB03-0320). All authors received training on
working with and the ethics of human specimen research from MD Anderson
Cancer Center. De-identified primary human endometrial tissue samples were
obtained from the tissue bio-specimen and pathology core facility at MD
Anderson Cancer Center. Frozen endometrial tissue sections were immediately
fixed in 4% paraformaldehyde/PBS for 20 minutes at room temperature. Samples
were permeabilized using 0.5% Triton in PBS for 15 minutes at room
temperature and then blocked for 30 minutes in blocking buffer containing 10%
fetal bovine serum (FBS) and 1% bovine serum albumin (BSA) diluted in PBS0.01% Tween 20 (PBST). Sections were subsequently incubated with the
following primary antibodies: Par3 (1:500, rabbit, Millipore, 07-330), Ezrin (1:500,
mouse, Invitrogen, 3C12), E-cadherin (1:1000, mouse, BD, 610182), Acetylated
Tubulin (1:1000, mouse, Sigma, T6793), ZO-1 (1:500, rabbit, Invitrogen, 617300), Notch1 (1:500, rabbit, Cell signaling, D1E11), Notch2 (1:750, rabbit, Cell
signaling, D76A6), Pan Cytokeratin (1:500, rabbit, Abcam, PA5-21985), c-Myc
(1:250, mouse, Santa Cruz, sc-40), and Pericentrin (1:1000, rabbit, Abcam,
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ab4448) overnight at 4°C. Slides were then washed three times in PBST and
incubated with secondary antibodies CY3 Rabbit (1:200, Jackson
Immunoresearch), Alexa 488 Mouse (1:200, Jackson Immunoresearch),
Phalloidin CY5 (1:250, Invitrogen), and 4’6’-diamidino-2-phenylindole
(DAPI,1:1000). Slides were washed two times in PBST, one time in PBS and
mounted with Vectashield (Vector Laboratories).
Staining of MDCK 3D cultures was adapted from previous descriptions
(237, 251), briefly, cultures were fixed in 3.7% Formalin in cytoskeletal buffer
(10mM 2-(N-morpholino)-ethanesulfonic acid sodium salt (MES) pH 6.1, 138 mM
KCl, 3mM MgCl2, 2mM EGTA) for 20 minutes at room temperature. Washed in
PBS and then permeabilized in 0.5% Triton/PBS for 20 minutes at room
temperature. Cultures were then washed in PBS and subsequently washed with
100mM Glycine/PBS for 15 minutes, 3 times. Cultures were blocked for 1 hour in
PBST/0.2% Triton/1% BSA/10% FBS and then left overnight at room
temperature with primary antibodies in blocking buffer. The MDCK cell culture
was washed in PBST 3 times for 20 minutes and then incubated in blocking
buffer with secondary antibodies for 1 hour at room temperature.
All mouse tissue was fixed in either 3.7% Formalin or 4% PFA in PBS.
Tissue was then either processed for paraffin-embedding (McCormick Scientific)
or OCT-embedding (Fischer Healthcare). H&E staining: Paraffin-embedded
samples were heated to 55°C for 20 minutes. Samples were incubated in
histoclear (3x) for 10 minutes each. Samples were progressively hydrated in
(100% (x2), 95% (x2), and 70% EtOH) ethanol and then deionized water for 22
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minutes. Samples were stained with Harris Hematoxylin modified (StatLab) for 7
minutes followed by washing in EtOH Acid (1% HCl in 70% EtOH) and bluing in
0.1% Sodium Bicarbonate. Samples were stained with 0.5% eosin Y (Sigma
Aldrich) for 5 seconds before being washed in 4x 100% EtOH. Samples were
incubated in HIstoclear (3x, 10 minutes) before being mounted with Permount
(Fischer). BrdU and Foxa2 staining: All mice were pulsed with BrdU (100µg per
gram of body weight) for 2 hours before being sacrificed. OCT-embedded
samples were thawed and dried for 10 minutes. Samples were then washed in
PBS 2x for 30 minutes each and permeabilized in 0.5% Triton/PBS for 20
minutes at room temperature. Samples were then washed in PBS, 3 times before
incubated in 1.5N HCl in PBS for 10 minutes. Slides were washed three times in
PBS. Samples were blocked for 1 hour in PBST/10% FBS and then left overnight
at room temperature with primary antibodies (BrdU [1:200, mouse, abcam,
ab6326]; Cleaved Caspase 3 [1:400, rabbit, Cell Signaling, Asp175] or Par3
[1:500, rabbit, Millipore, 07-330], FoxA2 [1:2000, rat, Seven Hills
BioReagents,WRAB-1200], b-catenin [1:1000, mouse, BD, 610153]) in blocking
buffer. The mouse tissue samples were washed in PBST 3 times for 20 minutes
and then incubated in blocking buffer with secondary antibodies for 1 hour at
room temperature. Other immunofluorescent stainings: OCT-embedded samples
were thawed and dried for 10 minutes. Samples were then hydrated in PBS 2x
for 30 minutes each and permeabilized in 0.5% Triton/PBS for 20 minutes at
room temperature. Samples were then washed in PBS. Samples were blocked
for 1 hour in PBST/10% FBS/1% BSA and then left overnight at room
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temperature with primary antibodies (Sox9 [1:250, rabbit, Santa Cruz, sc-20095];
E-cadherin [1:1000, mouse, BD, 610182], Par3 [1:500, rabbit, Millipore, 07-330],
ZO-1 [1:500, rabbit, Invitrogen, 61-7300], Muc1 [1:100, rabbit, Dan Carson’s
Laboratory(252)], Foxa2 [1:2000, rat, Seven Hills BioReagents,WRAB-1200],
Vinculin [1:300, mouse, Millipore, MAB3574], Myosin IIB [1:500, rabbit,
Biolegend, 909901], Rho [1:100, mouse, Santa Cruz, sc-418], pMLC [1:500,
rabbit, abcam, ab2480], b-catenin [1:1000, mouse, BD, 610153], Merlin [1:100,
rabbit, Santa Cruz, sc-331], P-cadherin [1:200, rat, Takara, M109], Yap [1:300,
mouse, Cell Signaling, 4912]) in blocking buffer. The mouse tissue samples were
washed in PBST 3 times for 20 minutes and then incubated in blocking buffer
with secondary antibodies, smooth muscle actin-Cy3 (1:200, mouse, Sigma,
C6198, SMA), or Phallioidin Cy3 (1:200, Invitrogen, A12380) for 1 hour at room
temperature. All samples were mounted with Fluoromount-G (Southern Biotech,
0100-01). All tissue samples and cells labeled were visualized using a Nikon A1
laser scanning confocal microscope.

2.3 Cell culture and reagents
Madin-Darby Canine Kidney (MDCK) cell lines and endometrial cancer
cell lines were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) with
10% fetal bovine serum (FBS). Generation of knockdown MDCK cell lines is
described below. Knockdown MDCK cells were selected for with puromycin
(0.7µg/mL). Re-expression cell lines were selected for with hygromycin (3µg/mL).
The g-secretase inhibitor DAPT (Sigma) was placed on cells at a concentration
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of 1 µg/ml in new media added with fresh DAPT every 24 hours for 48 hours for
BRDU and expression experiments and up to 72 hours for migration
experiments. Primary endometrial epithelial cells was isolated by a protocol
adapted from Eritja et al(253). Cells were isolated at P60 from Nf2lox/lox females
and kept in DMEM/F12 (Sigma, D8062) supplemented with 1%
antibiotics/antimycoctics (Sigma, A5965) and 1mmol/L Hepes (Corning cellgro,
25-060-Cl). Ad5CMVCre-eGFP (Adenovirus cre) was added at 80-90%
confluency at a concentration of 100 MOI/cell. Cells were incubated for 24 hours
in adenovirus cre before media was changed. Cells were fixed within 72 hours.
2.31 3D culture assay
MDCK 3D cyst formation was modified from previously described
work(254). In short, an 8-well chamber slide was pre-coated with a collagen
mixture (24uM Glutamine, 2.35mg/mL NaHCO3, 1x MEM, 20mM Hepes, 2mg/mL
Collagen I). MDCK cells were suspended in the same collagen mixture at a
concentration of 3x104. DMEM with 10% FBS was added 45 minutes after
placing the chamber slide in the 37°C incubator. The DMEM media was changed
every 2-3 days without disturbing the matrix/cell layer.
2.32 Generation of knockdown MDCK cell lines
Virus was produced by transfecting HEK293T cells at 80-90% confluency
with the pLK0.1 lentiviral expression vector obtained from Open biosystems
(Par3 kd clone ID: TRCN0000118134 and Ezrin kd clone ID: TRCN0000062462,
Table 5), Scr-shRNA and Nf2 kd shRNA in the pLK0.1 vector obtained from the
McClatchey lab (Table 5)(255). In addition, packaging vectors (VSVG and ΔVPR)
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were utilized. MDCK cells were infected with the virus and polybrene (1µg/mL) in
DMEM with 10% FBS. The following day, new media was added with puromycin
(0.7µg/mL) for selection. Knockdown was verified by Western blots.
2.33 Generation of primary knockout endometrial cell lines
Adenovirus cre was utilized to infect Nf2lox/lox endometrial epithelium.
Endometrial cells were infected with the virus in DMEM with 10% FBS. The
following day, new media was added. Knockout was verified by PCR.
2.34 Generation of overexpression endometrial cancer cell lines
The day before the transfection, cells were plated at 2x105 on each well of
a 6-well dish. Par3-myc was transfected in when the cells reached 50-70%
confluency using Lipofectamine LTX (Invitrogen) and Plus Reagent (Invitrogen).
The Par3-myc construct was a gifr from Iam Macara (Addgene plasmid #19388)
and has been previously described(256). 24 hours post-transfection, fresh media
was put on cells. Cells were fixed 48 hours after original transfection.
2.4 Quantitative RT-PCR
For Human Endometrial Tissue Samples: The qRT-PCR was performed
as indicated by Schlumbrecht et al(257). For MDCK cells, endometrial cancer
cells, and isolated endometrium: RNA was extracted by treating cells or tissue
with Trizol and chloroform. RNA was purified with 100% isopropanol and 75%
ethanol. RNA pellets were dissolved in 30-50uL of DEPC water at 55°C. RNA
purity was confirmed by nanodrop to have a A260/A280 ratio greater than 1.8.
cDNA was synthesized using a SuperScript First-Strand Synthesis kit. The cDNA
was analyzed using SYBR green quantification with the 7900HT Sequence
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Name

Sequence

Par3 kd 8134

5’-ATCATAAGATTTGTCGATGGC-3’

Par3 kd 8135

5’-TATCATAAGATTTGTCGATGG-3’

Ezrin kd

5’-TTTATTATCCACATAGTGGAG-3’

Nf2 kd

5’-GAGGAAGCAACCCAAGACGTT-3’

Scr-shRNA
5’-CAGTCGCGTTTGCGACTGG-3’
Table 5 shRNA oligos for MDCK cells and endometrial cancer cell lines.
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Detection System (Applied Systems). Primers used are found in the table, (Table
6). Samples were assayed in triplicate. Data were normalized to HPRT. Samples
below the limit of quantification were not included. The fold change of the DCT
compared to HPRT was utilized for analysis (2-DCT). For Isolated Endometrium:
Uteri were extracted and placed in Trizol. Samples were frozen until genotyping
was complete. Tissue was broken up using a cryogenic mortar and pestle. A
similar protocol to MDCK cells was utilized to isolate RNA and run qRT-PCR.

2.5 Cell extract preparation and Western blotting
For Western blots, cells were scraped off culture dishes and suspended in
Triton lysis buffer (1% Triton X-100, 50mM Tris-HCl pH 7.4, 140mM NaCl, 1mM
EDTA, 1mM EGTA, 1mM PMSF, 1mM Na3VO4, 1mM sodium fluoride, 1mM βglycerophosphate, 10µg/mL aprotinin, 10µg/mL leupeptin) followed by sonication.
Cell lysates were then centrifugation and the debris was removed. Bradford
assays were used to quantify the amount of proteins. Cell lysates (30µg) were
loaded onto SDS-PAGE gels and transferred to a PVDF membrane. Membrane
blots blocked for at least 1 hour in 5% milk in TBST. Primary antibody was added
overnight at 4°C. Primary antibodies include: (1:500, rabbit, Cell signaling,
D1E11), Notch2 (1:750, rabbit, Cell signaling, D76A6), Par3 (1:750, rabbit,
Millipore, 07-330), Ezrin (1:1000, mouse, Invitrogen, 3C12), Notch1 PTEN
(1:1000, rabbit, Cell Signaling, 138G6), Merlin (1:400, rabbit, Santa Cruz, sc-332)
and β-tubulin (1:1000, Sigma/Santa Cruz, T7816/sc-9104). Secondary antibodies
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Name
b Actin

GAPDH
HPRT
h-HPRT

Notch1 -1
Notch1 -2
Notch2 -1

Notch2 -2

Notch3 -1

Notch3 -2

Notch4 -1

Notch4 -2

JAG1 -1
JAG1 -2
JAG2 -1
JAG2 -2
DLL1 -1

F/R

Sequence

F

5’-CTAAGGCCAACCGTGAAAAG-3’

R

3’-ACCAGAGGCATACAGGGACA-5’

F

CCCTTCATTGACCTCAACTACA

R

ATGACAAGCTTCCCGTTCTC

F

AGCTTGCTGGTGAAAAGGAC

R

TTATAGTCAAGGGCATATCC

F

TTCTGTGGCCATCTGCTTAG

R

GTTTAGGAATGCAGCAACTGAC

F

CAGCCCTTGTCTCCAGAATG

R

TTGGCACCGTTCTTACAGG

F

GGATGGCATCAATAGCTTCATG

R

CCAGGGTCACAGTCACATTTG

F

TCGGGATAGCTATGAGCCCT

R

GGCATGTTGCTTTCCCCAAC

F

ATTTCATGCAGGTTAGAGAAGGAC

R

CTGTCTGAGAGCTCAGTGACCTTA

F

ATCAACCGCTATGACTGTGTC

R

TCCATTTTCCCCATCCACG

F

GCTGCGAAACTGATGTCAAC

R

GCTACTCTGACACTCATCCATG

F

AGTAACCCCTCAAACACAGC

R

ACAAATCCACACCCATCACC

F

GGTAAACCCATGTGAGTCCAG

R

AGTTCTGTCCATTGTAGCCTG

F

GAAAGTGCCCAGAGCCTAAA

R

CAGGACAGCTGAAGAACTGAA

F

GAACCTGATTGCGAGCTACTAC

R

GGTGGACAGATACAGCGATAAC

F

GGACGCCAATGAATGTGAAG

R

CGGGATGCAGAGACAGTAATAG

F

ACCTGATTGGTGGCTATTACTG

R

CTGCCCATGACAGTCGTTTA

F

CCGATGACCTCACAACAGAAA
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DLL1 -2
DLL3 -1
DLL3 -2
DLL4 -1
DLL4 -2
P21 -1
P21 -2
HeyL -1
HeyL -2
Hey1 -1
Hey1 -2
Hey2 -1
Hey2 -2
Hes6 -1
Hes6 -2
Ccnd1 -1
Ccnd1 -2
Myc -1

R

CACACGAAGCGGTAGGAATAC

F

GCAGATCAAGAACACCAACAAG

R

GTCCAAAGGACAGCAAGA

F

GAATCACCCTGAAGATGGAGAC

R

GCTCCAAAGGACAGCAAGA

F

CGGATGGACCTTGCTTCAAT

R

ACAGTTGGAGCCTTGGAATC

F

GCTCAAGAACACAAACCAGAAG

R

GGGCCAGATTATAGTCCAATGT

F

TCCACTGGCATCTGTGTTTC

R

CCTCCTCTCTCCTCTCTGATTT

F

CATCCTGGCCTGTACTGTT

R

CTTGCCCTTCAGAGGCTTATAG

F

AGCTGAACAAGGAGTCAGATG

R

CAGGGCCAGAAGAGACAATAA

F

AGTTGATCTTGGGTTCACTCTC

R

ACCAGAAAGGCTTGGGAATAG

F

GTTCTTCATCCAGGGAGCTCTAAA

R

GAGGAAGATGCCTTCACAGATAG

F

GCTATGGACTATCGGAGTTTGG

R

CTGGGAGGCGTAGTTGTTAAG

F

GCCCGATATCTGAGCATCATT

R

CGTAGTTGTTAAGGTGGGAGAC

F

GCGGCGAGATCGGATAAATAA

R

TGATCTACCGTCATTTGCAGTAT

F

AACATCTCAGATTATGGCAAGAAAG

R

CCAGTCGTCTCAACTCAGATAAA

F

AAAGCGCGCCTAGACAAA

R

CCGTCTGGTCTTGTAACTTGAT

F

CCAACACCTGTCGCTCTT

R

CTTGTAACTTGATGCCCATGAC

F

GCCCTCCGTATCTTACTTCAAG

R

GCGGTCCAGGTAGTTCATG

F

CATCTACACTGACAACTCTATCCG

R

TCTGGCATTTTGGAGAGGAAG

F

GCTGTTTGAAGGCTGGATTTC
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Myc -2
Sox9 -1
Sox9 -2
Sox17 -1
Sox17 -2
Wnt7a -1
Wnt7a -2
Hoxa11 -1
Hoxa11 -2
Birc2
Birc3
CTGF
Merlin -1
Merlin -2

R

GATGAAATAGGGCTGTACGGAG

F

CGATTCCACGGCCTTCTC

R

TCTTCCTCATCTTCTTGCTCTTC

F

CAAGACTCTGGGCAAGCTC

R

GGGCTGGTACTTGTAATCGG

F

GCCGACTCCCCACATTC

R

CGCTTCAGATCAACTTTGCC

F

CGATGAACGCCTTTATGGTG

R

TTCTCTGCCAAGGTCAACG

F

AATATGGCCCACTCACACTG

R

TTTCTCTGTCTTCCCTGTCTTG

F

ACGAGTGTCAGTTTCAGTTCC

R

AATCGCATAGGTGAAGGCAG

F

TTACACAATAACGAGGCGGG

R

TTGTCCTTGAGCACGTAGC

F

AGGAGAAGGAGCGACGG

R

GGTATTTGGTATAAGGGCAGCG

F

CTAAACTAGCATCCCTACCCTG

R

ATCAGTTCTTGCCTCTTCCG

F

GAAGAAAATGCTGACCCTACAGA

R

GCTCATCATGACGACATCTTTC

F

AGAGAGGAGCAGATGGAGCA

R

TTTGTTCTTCCGGATTAGTGC

F

GGGCCTCTTCTGCGATTTC

R

ATCCAGGCAAGTGCATTGGTA

F

CTCCTGCATACCTGCATATCTC

R

CTAAGCCAGTCCACACTTCTAC

F

CAGGGAAGAGAAGGCTAGAAAG

R

ATTGGGTTCATGGGTGGATAG

Table 6 qRT-PCR primers for MDCK cells, endometrial cancer cells, and isolated
endometriums
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were put on the next day for at least 30 minutes. Protein expression was
depicted using enhanced chemiluminescence on a LiCor machine.

2.6 Image processing, analysis, and densitometry
All tissue samples and cells were visualized using a Nikon A1 laser
scanning confocal microscope or a Nikon 80i upright Fluorescent Microscope.
Images were processed using the Nikon-Elements software (Nikon). Quantitative
analysis of endometrial tumor samples was performed blind by an independent
investigator. Quantitative analysis of the mouse tissue including myometrium, cell
adhesion angles, BrdU, and Cleaved Caspase 3 (CC3) calculations was
performed utilizing ImageJ. Line intensity plots (Phalloidin, pMLC, [Vinculin,
Myosin IIB], Sox9, [P-cadherin, E-cadherin], Muc1, and FoxA2 were also
performed on ImageJ analysis. Densitometry was performed by Image Studios
Version 3.1 using the data from the LiCor machine.

2.7 Statistics
The quantitative data in this dissertation was analyzed utilizing either twotailed Student’s t-test or ANOVA. Data that was found to be significant was
marked with some form of an asterisk and discussed in figure legeneds. Data
was considered significant if P<0.05.
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Chapter 3: Merlin regulates endometrial gland development through
polarized signals.

3.1 Introduction
Female infertility is a complex problem that is still not well understood. In
the United States, 17% of women need infertility assistance(258, 259). In a
multitude of animal models the endometrium has been found to be a common
cause of impaired fertility, specifically when endometrial glands are lost. The
endometrium is composed of stromal cells that surround the luminal and
glandular epithelium. The luminal epithelium, the epithelium surrounding the
uterine cavity, gives rise to glandular epithelium that invaginates into the stroma
after birth. The glandular epithelium is hypothesized to secrete mucins to protect
the uterus from infection and histrophs to facilitate proper uterine and blastocyst
response during pregnancy(197, 260).
Endometrial glands are observed in mouse models to be necessary for
protein secretion correlated with successful implantation as well as a source of
nutrients as the placenta is generated(17, 18, 261). Data examining fertile and
infertile women demonstrated that increased plasma levels of Interleukin 1b and
Tumor Necrosis Factor were predictive of a successful implant in women
undergoing in vitro fertilization(262, 263). Examining how the endometrial glands
form may lead to a better understanding of how female infertility arises and can
be potentially treated.
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Endometrial glands are formed through a process called tubulogenesis
that occurs postnatally in both mice and humans. There are many methods of
tubulogenesis that have previously been reviewed but endometrial glands are
thought to go through a budding process(264). At postnatal day 0 (P0) in mice
the endometrium has only the central lumen of epithelial cells. Beginning at P5,
small invaginations begin to form off the main luminal epithelium and buds start
to develop at P7(265). At P8 a portion of the buds begin to extend and form
structures resembling teardrops(19). At P11, elongation of the initial buds and
teardrops begin to rotate forming a more complex, spiral shape gland by
P21(19). Following the onset of puberty around P60, a gland will consist of
branched structures coming off of a main stem (Figure 1d)(20). Development of
the endometrial gland involves both Wnt and Notch signaling, however, what how
these pathways regulate elongation or branching is still not known. There are
many genes that have been associated with gland formation through information
obtained from different mouse models manipulating genes including FoxA2, bcatenin, and Notch1 (Table 1)(21, 26, 46). While the molecular mechanisms
underlying endometrial gland development have begun to be examined, there
are still many unanswered questions that could help us understand both
endometrial gland formation and infertility.
Endometrial gland formation takes a collaboration between cell adhesion
and apicobasal polarity to properly form glandular architecture. Without proper
cell adhesion, the epithelium would not hold together to form the discrete
structures as is shown when E-cadherin is deleted from the endometrium(45).
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Without cell polarity, polarized migration and cell adhesion do not properly
function. In order to understand how apicobasal polarity and cell adhesion are
involved in endometrial gland formation, we examine a protein that is known to
couple proper apical junction maturation and polarity establishment, Merlin.
Originally discovered for its role in Neurofibromatosis Type 2, a benign tumor
disease, it has since been shown in vivo to be important for the development and
homeostasis of epithelial tissues including the skin, kidney, and liver(122, 224,
225). Nf2-/+ mice were found to be sub-fertile however why these mice have
reduced fertility is not known(219). Utilizing endometrium specific Merlin
knockout mice, we were able to determine the role of Merlin during endometrial
development and how it may lead to infertility.

3.2 Results
3.21 Merlin deletion causes loss of gland formation and female infertility.
Conditional loss of Merlin in endometrial epithelium (Nf2lox/lox; Wnt7a-cre;
Nf2eeKO) or in the endometrial epithelium and stroma (Nf2lox/lox; PR-cre;
Nf2seeKO) causes a loss of endometrial glands before puberty at P21 and is not
due to a delay in gland formation as no glands are observed during estrus at P60
(Figure 4a-e, not shown). Wild-type mice at P21 have an average of 8-10
endometrial gland cross sections per uterine section, while Merlin null mice have
less than one (Figure 4f-g).
Since endometrial glands are necessary for proper female fertility, we
examined whether fertility was intact. We performed a fecundity study over 3
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Figure 4 Merlin loss in the endometrium causes a loss of glands.
Wild-type (a) and Nf2lox/lox; Wnt7a-Cre (Nf2eeKO, b) H&E staining show the loss of
glands on the Nf2eeKO uteri. Magnification of the wild-type (c) glandular epithelium, (d)
luminal epithelium and the Nf2eeKO (e) luminal epithelium. Quantifications of the
number of glands observed in a cross-section of wild-type and Nf2eeKO mice (f, n=13)
or wild-type and Nf2lox/lox; PR-Cre mice (Nf2seeKO, g, n=3). A table summarizing the data obtained from a 3-month fecundity study with the Nf2seeKO mice (h).
Quantifications of the number of litters a single mouse had (i) or the average number of
pups per litter (j) within the fecundity study.
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months where 6 Nf2seeKO mutants and 6 wild-type female mice were mated to
wild-type male mice. The 6 wild-type mice on average had 3 litters with 7 pups
per litter, while the Nf2seeKO mice did not have any litters (Figure 4h-j).
Vaginal plugs were observed in the Nf2seeKO mice similar to wild-type
littermates suggesting mating and estrus is normal in the female mice. Weight
was examined after plugs were observed. Wild- type mice showed increases in
weight around E7.5. Nf2seeKO mice never gained weight during the normal
gestation period of 19 days. This suggests that the pregnancy is lost before E7.5
and that Nf2 mutant female mice are infertile.
In addition to fertility, endometrial glands have distinct markers from the
luminal epithelium. Previous studies have shown that wild-type endometrial
glands have nuclear Sox9 staining and we observe similar results that is
quantitated by a line plot (Figure 5a, g, white line denotes line quantitation)(22).
We also examined nuclear Sox9 in Nf2eeKO and Nf2seeKO endometrial
epithelium and found the luminal epithelium had a similar intensity of Sox9 as the
wild-type luminal epithelium (Figure 5a-c, g). Additionally, another endometrial
gland marker, FoxA2(21), was not found in the majority of Nf2eeKO or Nf2seeKO
endometrial epithelium, while the wild-type mice had intense FoxA2 nuclear
staining in the glandular epithelium (Figure 5i-m). The Nf2eeKO and Nf2seeKO
luminal epithelium did exhibit some nuclear FoxA2 at discrete locations,
specifically near curves in the luminal epithelium (Figure 5k-l) that had a similar
intensity to the glandular epithelium of the wild-type tissue (Figure 5i, k, l, n). A
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Figure 5 Endometrial Gland Markers within the Nf2eeKO and Nf2seeKO mice at
P21.
Sox9 was examined in wild-type (a, a’), Nf2eeKO (b, b’), and Nf2seeKO (c, c’) mice.
Muc1 was examined in wild-type (d, d’), Nf2eeKO (e, e’), and Nf2seeKO (f, f’) mice. The
line intensity of Sox9 in wild-type glandular epithelium, as well as, wild-type, Nf2eeKO,
and Nf2seeKO luminal epithelium compared, the left area of the line represents the
basal boundary of the cell (g). The line intensity of Muc1 staining in wild-type glandular
and luminal epithelium compared to Nf2eeKO and Nf2seeKO luminal Muc1 staining (h).
FoxA2 staining in wild-type endometrial glands (i, i’), wild-type (j, j’), Nf2eeKO (k, k’),
and Nf2seeKO (l, l’) luminal epithelium. Line plots of FoxA2 intensity in wild-type
glandular epithelium compared to wild-type, Nf2eeKO, and Nf2seeKO luminal epithelial
cell (m), left region of line plot is the basal boundary of the cell. Line intensity of FoxA2 in
wild-type endometrial glands compared to Nf2eeKO and Nf2seeKO luminal epithelium
(n). Immunofluorescence images of SMA (smooth muscle actin) in wild-type (o, o’),
Nf2eeKO (p, p’) and Nf2seeKO (q, q’) uteri. Quantification of the density of the outer
radial myometrium (n=3, r). Quantification of the density of the inner longitudinal
myometrium (n=3, s). Quantification of the length of longitudinal nuclei (n=3, t). *P<0.05
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similar phenotype was observed with Sox9 in some samples of Nf2eeKO and
Nf2seeKO luminal epithelium though not as consistent (not shown).
Endometrial glands are hypothesized to secrete more mucins than the
endometrial luminal epithelium. Thus, we were interested if Muc1 decreased in
the endometrium of our Nf2 mutant mice. We observed that the wild-type mice
exhibited a higher intensity of Muc1 staining in the glandular epithelium then in
the luminal epithelium (Figure 5d, h). Compared to wild-type luminal epithelial
cells, Nf2seeKO and Nf2eeKO luminal epithelium showed increased Muc1
staining on portions of the epithelium (Figure 5d-f, h). Interestingly, these
Nf2eeKO and Nf2seeKO luminal Muc1 stainings, were a similar intensity as the
glandular staining of the wild-type mice (Figure 5h). These increases in glandular
markers provide evidence that the mutant luminal epithelium is capable of
differentiating into glandular epithelium but is unable to assemble the glandular
architecture.
The endometrium is known to be necessary for proper myometrium
development(266). Given the alterations in glandular architecture in the Nf2deficient endometrium, we were interested in how the myometrium was affected
in the Nf2eeKO and Nf2seeKO uteri. To examine the myometrium, we stained for
smooth muscle using SMA (smooth muscle actin) and found that at P21, the
longitudinal and radial SMA populations look relatively similar between the wildtype and mutant mice (Figure 5o-q). When examined closely, we determine the
number of nuclei increased in the outer, radial myometrium compared to wildtype mice (Figure 5r). Similarly, the inner, longitudinal cells showed a slight
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increase in nuclei density compared to the wild-type myometrium (Figure 5s). In
both myometrial cell types the Nf2eeKO mice showed the highest density of cells
compared to the wild-type or Nf2seeKO mice. To understand if the change in
density was caused by a difference in nuclei size, we measured the length of the
longitudinal myometrial nuclei and did not observe a substantial difference
(Figure 5t).

3.22 Apicobasal polarity and junction condensation is lost in Merlindeficient tissue
Since there was an obvious change in histology in the Nf2eeKO and
Nf2seeKO mice, we wanted to examine whether cell polarity and cell:cell
adhesion were altered. We first verified that Merlin was disrupted in our mutant
endometrium (Figure 6a). Endometrial tissue was isolated from wild-type or Nf2deficient mice and analyzed by PCR to determine if Cre mediated recombination
had occurred. Using three separate PCR primer sets we established whether the
uterine tissue was heterozygous or homozygous for the Nf2 targeted allele. In
addition, we verified the presence of Cre and deletion of Exon 2 following Cremediated recombination. We found that Exon 2 had been recombined in tissue
expressing Cre indicating deletion of Merlin (Figure 6a). Since Merlin has
previously been shown to disrupt apicobasal polarity, specifically the Par
complex, we examined the localization of Par3 in Merlin null endometrial
tissue(122). While Par3 localizes to the apical surface of the luminal and
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Figure 6 Merlin loss causes disruption of apicobasal polarity without altering
apical junctions.
Merlin loss was examined by PCR for recombination of the targeted Nf2 allele (a). Par3
staining in wild-type luminal epithelium (b) and glandular epithelium (c) show apical
localization in wild-type, however Nf2eeKO luminal epithelium (d) has diffuse staining.
ZO-1 staining in wild-type (e, e’) and Nf2eeKO (f, f’) show minimal changes to the apical
localization. b-catenin staining in wild-type glands (g, g’), wild-type luminal epithelium (h,
h’), and Nf2eeKO luminal epithelium (i, i’) show no changes. Yellow dotted line signifies
the epithelial tissue. Staining of E-cadherin and P-cadherin in wild-type (j, l) and
Nf2eeKO (k, m) mice at P7 (j-k) and P21 (l-m) show an increased luminal staining of Pcadherin and minimal changes to E-cadherin at P21. Line intensity graphs of colocalization of wild-type and Nf2eeKO (n-o) show an increase of P-cadherin at the apical
lumen at both P7 (n) and P21 (o).
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glandular epithelium in wild-type mice (Figure 6b-c), there is loss of Par3 at the
apical surface in the Nf2-deficient luminal epithelium (Figure 6d). This suggests
apicobasal polarity is disrupted similar to what has been observed in other
epithelial tissues(122).
Additionally, since Merlin is critical in junctional maturation, we were
interested in whether apical junction proteins like ZO-1, b-catenin, and Ecadherin were mislocalized. ZO-1 was examined by immunofluorescence and
found to still localize to the apical junctions (Figure 6e-f).
This was surprising since in other Merlin-deficient epithelial tissues ZO-1
localizes to the cytoplasm(122). Proper localization of ZO-1 can
indicate that tight junctions are able to form, however, it does not address
whether the junctions are fully functional. Additionally, b-catenin, an adherens
junction protein, was examined for proper localization to the apical junctions.
Nf2eeKO mice had similar localization of b-catenin to the luminal epithelial
membrane as wild-type littermates on the endometrial luminal and glandular
epithelium (Figure 6g-i). E-cadherin was also examined in Nf2eeKO mice
compared to wild-type mice. E-cadherin appeared relatively similar between wildtype and mutant mice (Figure 6j’-m’). There was some intense punctate ECadherin staining noted in a subset of the Nf2eeKO mice, not observed in wildtype littermates (not shown). Thus, the majority of proteins in adherens junctions
appear to localize properly.
Interestingly, P-cadherin is another cadherin that is known to be
expressed within the endometrium(267–269). P-cadherin is involved in mammary
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tubulogenesis where it is expressed on the cap cells in terminal end buds(270).
Bazelliéres et al. showed that P-cadherin and E-cadherin can play different roles
in mechanical stress and cellular tension(271). E-cadherin has been shown to
strengthen the cell adhesions, while P-cadherin regulates the intercellular
tension(271). Thus, we decided to examine P-cadherin in the pre-cycling uterus.
In wild-type uteri, P-cadherin is dispersed throughout the membrane of the
epithelium, while in the Nf2eeKO mice, P-cadherin localizes to the apical lumen
(Figure 6j”-m”). This P-cadherin apical localization occurs early during gland
development at P7 (Figure 1d, Figure 6j”-k”) and intensifies over time observable
at P21 (Figure 6l”-m”).

3.23 Proliferation decreases and tension increases in Merlin-deficient
tissue
In order to determine why the correct endometrial gland architecture did
not form, endometrial tissue was examined at an earlier stage of gland formation
e.g. P7 (Figure 1d). Gland formation has been examined in a multitude of
tissues, however the exact mechanism by which the endometrium forms glands
is not completely understood. In order for the buds to form and then go through
tubulogenesis, any combination of proliferation and apoptosis may cause the
cellular changes necessary for gland formation. Additionally, since changes in Pcadherin were observed (Figure 6j”-m”), local changes in cell:cell and cell:matrix
tension likely play a role in the elongation of the gland structure. Proliferation was
examined following a 2-hour pulse of BrdU. In Nf2eeKO mice, there was a
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decrease in BrdU incorporation in both the epithelium and the stroma (Figure 7ab). The epithelium and the stroma showed about a 5% decrease in BrdU
incorporation (Figure 7e-f). This suggests there is a small decrease in cellular
proliferation in the endometrium due to Merlin loss in the epithelium. In addition
to proliferation, we examined apoptosis using the apoptotic marker cleaved
caspase 3 (CC3). CC3 levels were low in both wild-type and Nf2eeKO mice and
no significant difference was observed (Figure 7c-d, g).
Besides examining proliferation and apoptosis, we were interested in how
tension was affected in the Nf2eeKO endometrium since P-cadherin localization
changed. Co-localization of Vinculin and Myosin IIB (myoIIB) indicates an
increase in cellular tension. When epithelium have low amounts of tension at
cell:cell contacts in particular at the adherens junctions, this causes a-catenin to
form a tertiary structure decreasing the association of actin, myoIIB, and Vinculin
to the adherens junction(272). When a-catenin is under tension then myoIIB and
Vinculin are able to associate with the junctional complex(272). In addition,
Vinculin is stabilized at Focal Adhesions (FAs) on the basal membrane as actinmyosin related tensionincreases(273, 274). Thus, co-localization of Vinculin and
myoIIB can indicate cell:cell and cell:ECM contacts are under tension.
Examination of wild-type endometrium shows little to no co-localization of
Vinculin and myoIIB except in small sections at the basal membrane of the
luminal epithelium (Figure 8a). The Nf2eeKO mice however, had co-localization
of Vinculin and myoIIB across a majority of the basal membrane of the luminal
epithelium (Figure 8b). The co-localization was more intense in Nf2eeKO

76

77

Figure 7 Proliferation and Apoptosis within the developing endometrium.
BrdU staining, signifying the amount of proliferation in wild-type (a, a’) and
Nf2eeKO (b, b’) endometrial epithelium and stroma. Cleaved Caspase 3 (CC3)
showing the amount of apoptosis in the wild-type (c, c’) and Nf2eeKO (d, d’)
endometrial epithelium. Quantification of the amount of BrdU positive cells within
the luminal epithelium (e) and endometrial stroma (f). Percent of cells that have
CC3 in the luminal epithelium of wild-type versus Nf2eeKO mice (g). * P<0.05
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endometrium compared to any co-localization observed in the wild-type
endometrium (Figure 8a-b, e). In addition, pMLC (phospho-Myosin Light Chain)
is known to indicate areas of high cellular tension. ROCK (Rho-associated
protein kinase) phosphorylates MLC which causes myosin ATPase to activate
actin(275). We observed an increase in the intensity of pMLC at the basal
membrane in Nf2eeKO mice compared to wild-type mice (Figure 8c-d). A
comparison of line plots showed a large increase of pMLC on the basal
membrane of Nf2eeKO endometrium compared to wild-type endometrium
(Figure 8f).
To examine tissue tension in a morphological manner, we utilized the
cellFIT program that generates mathematical equations and common
assumptions to map differing areas of tension within a cell sheet(276).
Unfortunately, cellFIT was not able to obtain true cell measurements in uterine
tissue sections resulting in inconsistent readouts even on the same image. While
we continued to examine other mathematical modeling systems, we found a
majority of systems are not designed for in vivo tissue, but rather cell
culture(277). Cell culture based modeling systems have found that utilizing the
angle of cell:cell and cell:ECM interactions can help determine where high vs.
low tension is located (Figure 8h)(277). Using this strategy, we measured the
cell:cell and cell:ECM angles, in wild-type samples (n=3) and determined the
wild-type cell:cell: angles are obtuse, while a majority of the mutant (n=3) cell:cell
angles are acute suggesting that the mutant cells are compressing their apical
surface (Figure 8g). In addition, the cell:ECM interactions showed
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Figure 8 Increases in tension at the basal membrane corresponds to an
increase in F-actin at the apical membrane in Nf2eeKO mice.
Wild-type (a) and Nf2eeKO (b) endometrium show differing co-localizations of
Myosin IIB (a’-b’) and Vinculin (a”-b”). pMLC is increased at the basal
membrane of Nf2eeKO (d, d’) versus wild-type (c, c’) luminal epithelium.
Comparison of the intensity of Myosin IIB and Vinculin in wild-type and Nf2eeKO
uteri (e). Quantification of pMLC intensity in wild-type versus Nf2eeKO uteri (f).
Quantification of the angles observed between the extracellular matrix and the
basal membrane (Cell:ECM) or apical junctions (Cell:Cell) of the luminal
epithelium in wild-type (g-h, Cell:ECM median=88°, Cell:Cell median=98°) and
Nf2eeKO (h-I, Cell:ECM median=96°, Cell:Cell median=81°) mice. Phalloidin
staining of F-actin in wild-type (j, j’) and Nf2eeKO (k, k’) endometriums (j-k).
Comparison of the line intensity of Phalloidin at the apical surface of wild-type
and Nf2eeKO mice from (j-k) images (l). White lines denote where line intensity
was measured (j’, k’).
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obtuse angles in the mutant mice compared to acute angles in the wild-type mice
(Figure 8g, i).
In order for this switch of cell interaction angles to occur, we hypothesized
that mutant endometrium is under increased tension. Additionally, because of
the direction of the angle changes, we postulated that this could be from
increased apical constriction producing a contractile actin ring on the apical
surface of the mutant endometrial epithelium. To examine whether an actin ring
was present, we stained endometrial tissue with Phalloidin, an F-actin dye, and
found that Nf2eeKO tissue has more intense Phalloidin staining around the apical
lumen than the wild-type endometrium (Figure 8j-l). This indicates the potential
changes in tension observed at the basal membrane may be from apical
constriction pulling the cells in a manner where they are unable to form a
glandular structure.

3.24 Wnt signaling is downregulated in Merlin mutants
In order to understand what signaling pathways may be involved in the
lack of adenogenesis, we examined pathways known to be regulated by Merlin
including the Hippo and b-catenin signaling pathways. Merlin is well known for
the tissue specific role it can play as a positive regulator of Hippo signaling in
Drosophila and in mammalian brain and liver(223, 278). Hippo signaling is
inactive when YAP (Yes-associated protein) or Taz (transcriptional co-activator
with PDZ-binding motif) translocates into the nucleus and interacts with
transcription factors like TEAD (TEA domain-containing transcription factor
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family) proteins to increase target gene expression (Figure 2d). A kinase complex
made up of MST1/2 (Mammalian Ste20 Kinases 1/2), Sav (Salvador), MOBKL
A/B (Mps One Binder Kinase activator-like A/B), and Lats1/2 (Large Tumor
Suppressor 1/2) phosphorylate YAP sequestering it to the cytoplasm where it is
degraded(54). Wild-type and Nf2eeKO mice at either P7 or P21 showed no
nuclear Yap staining, suggesting that Hippo signaling is not increased in the
Merlin-knockout uterus (Figure 9b-e). We confirmed the staining with embryonic
osteoblasts in cartilage primordium where nuclear YAP staining has been
previously shown (Figure 9a)(279). To confirm these results, we examined YAP
downstream targets BIRC3 (Baculoviral IAP repeat containing 3) and CTGF
(Connective tissue growth factor) by qRT-PCR in uteri isolated from Nf2eeKO
female mice at P7. While CTGF did not show a significant change between wildtype and Nf2eeKO mice (Figure 9f), BIRC3 did show an increase in expression
suggesting some targets of YAP may be increased (Figure 9f).
Numerous observations indicate that Wnt signaling is involved in
endometrial gland development so we also examined Wnt signaling regulators
and downstream targets (Figure 9g-l). We noticed a slight increase in Axin1 and
Axin2 (Figure 9g). In addition, we observed an increase in Ccnd1 expression,
though Ccnd1 is downstream of multiple pathways that may be affected in
Nf2eeKO mice (Figure 9l). Furthermore, Wnt7a expression increased in the
Nf2eeKO uterus at P7, but Wnt7a has been implicated as a ligand utilized in the
planar cell polarity pathway, potentially indicating planar cell polarity is being
affected in the Nf2eeKO mice (Figure 9k). Myc, a common Wnt downstream
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Figure 9 Hippo and Wnt signaling in Nf2eeKO Mice.
Yap staining in embryonic osteoblasts in cartilage primordium as a positive
control (a, a’). Yap staining in wild-type (b, b’, d, d’) and Nf2eeKO (c, c’, e, e’)
endometrium. qRT-PCR of Hippo signaling downstream targets CTGF and
BIRC3 in wild-type and Nf2eeKO mice (f). Axin1 and Axin2 mRNA expression in
wild-type and Nf2eeKO mice (g). qRT-PCR of Myc (h), Sox9 (i), Sox17 (j),
Wnt7a (k), and Cyclin D1 (l) in wild-type and Nf2eeKO mice. *P<0.05, **P<0.01,
***P<0.005
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target was significantly decreased in Merlin-deficient endometrium (Figure 9h).
Additionally, another Wnt downstream target, Sox9 was slightly decreased
(Figure 9i). Sox17 is known in mouse models of gastric cancer to be involved in a
feedback loop with Wnt signaling. When Wnt signaling increasing, it results in an
increase in Sox17 that suppresses additional Wnt signals(280). Sox17
expression was shown to increase in Nf2eeKO mice (Figure 9j)(25, 281). This
indicates that during initiation of endometrial gland formation, Wnt signaling is
decreased in Merlin-deficient endometrium.

3.3 Summary
Previous reports show that Nf2 heterozygous mice have decreased
fertility, however whether this is due to alterations of the uterus are not
known(282). We generated a conditional knockout of Merlin in the uterus utilizing
the Nf2lox/lox mouse crossed to either the Wnt7a-Cre or PR-Cre mouse to create
endometrial epithelial specific mutants (Nf2eeKO) and whole endometrium
knockouts (Nf2seeKO) respectively. Both mutants exhibited an aglandular
phenotype and Nf2seeKO mice were infertile. Given previous work
demonstrating endometrial glands are essential for proper fertility, the infertility in
mice lacking Merlin in the uterus could be attributed to decreased or absent
gland function. We examined endometrial gland specific transcription factors and
Muc1 expression in Nf2eeKO and Nf2seeKO mice. While a majority of the
luminal epithelium in Nf2eeKO and Nf2seeKO mice showed similar intensity of
Sox9, FoxA2, and Muc1 as the wild-type luminal epithelium, there were distinct
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regions that showed increased intensity. Interestingly, the discrete areas of
increased Sox9, FoxA2, or Muc1 had similar levels as wild-type glandular
epithelium. This suggests that Nf2eeKO and Nf2seeKO luminal epithelium can
differentiate in to glandular epithelium correctly but cannot form the proper
architecture.
In order to understand why the glandular architecture may not form
properly, we examined proliferation, apoptosis, and cellular tension within the
tissue. We found there were slight decreases in proliferation in Nf2eeKO mice
compared to wild-type mice. Additionally, we determined that cellular tension was
increased at the basal membrane of the luminal epithelium in Nf2eeKO mice
compared to wild-type mice. We found an increase of F-actin at the apical
surface of Nf2eeKO luminal epithelium compared to wild-type mice suggesting
an increase in apical constriction. The apical constriction may be pulling on the
basal membrane causing the increase in tension at the cell:ECM interface.
Merlin regulates Hippo signaling, cell adhesion, and cell polarity. When
examined by immunofluorescence, only apicobasal polarity was significantly
affected. However, what signaling pathways may be involved in Nf2eeKO and
Nf2seeKO endometrial gland formation were not clear. We found that other Wnt
signaling mutant mice have a similar phenotype and a canonical Wnt signaling
downstream target was decreased as measured by qRT-PCR. Interestingly, we
also examined a Wnt signaling negative regulator, Sox17, measured by qRTPCR and found Sox17 was increased in the Nf2-deficient mice at P7. Alterations
in tension and cadherins can modulate the levels of Sox17(283) and the nuclear
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localization of b-catenin(284). This indicates that the observed increase in apical
P-cadherin may be causing the decrease in Sox17 expression. Another
hypothesis is that the changes in tension in the Nf2eeKO mice cause the
decrease in Wnt signaling. This study helps understand the role of polarity,
tension, and Merlin within endometrial gland development and female infertility.
Since there are 3.53 million women who are unable to become pregnant in the
United States, these mouse models will be helpful in understanding female
infertility and potential treatments (259).
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Chapter 4: The Role of Merlin in Endometrial Homeostasis

4.1 Introduction
Merlin is necessary for proper development of the endometrium (Chapter 3).
Merlin has been shown in other epithelial organs to cause both developmental
diseases and carcinomas(224, 225). An example is the role Merlin plays in
epidermal barrier development, where it regulates establishment of adherens
junctions and apicobasal polarity(122). Merlin-deficient skin no longer forms an
organized stratified squamous epithelium but rather a disorganized epithelial
tissue that loses organ function(122).
Similar to the skin, the uterus is a complex organ that is shed and remodeled
frequently through menstruation or estrous. The uterus has a multitude of
functions focused around reproduction, including generating a suitable
environment for an embryo. The intricacy of the uterus can lead to a variety of
FRT diseases that are still not completely understood including endometriosis,
uterine fibroids, and endometrial cancer. Menstruation and estrous cause a reorganization of the uterus with each cycle; during this process, both cell adhesion
and cell polarity are re-established. Since Merlin connects cell adhesion and
apicobasal polarity together(122), Merlin may be necessary for proper
homeostasis in the uterus as well. Within this dissertation, homeostasis is
defined as the proper maintenance of the mouse or human endometrium and
myometrium architecture. Using TCGA (the Cancer Genome Atlas) data we
found Merlin is mutated, deleted, or amplified in 5% of human endometrial
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cancers(164, 165). Merlin has also been shown to be regulated posttranslationally when homeostasis is disrupted in the breast as well(285). This
implies that Merlin may be affected in more cases of endometrial cancer as well.
Merlin (gene name: NF2) was originally found in Neurofibramotosis type 2, a
central nervous system tumor disorder, where there was a loss of heterozygosity
of Merlin. Interestingly, Merlin has been found to cause carcinomas through a
multitude of pathways including EGFR and Wnt signaling(286, 287). How Merlin
affects the uterus is not yet well understood, our current knowledge includes the
fact that Nf2+/- mice are subfertile(219) and from Chapter 3 that conditional Merlin
knockout causes a loss of endometrial glands and infertility. Understanding how
Merlin is involved in homeostasis of the adult mouse uterus may help us learn
more about other endometrial diseases like cancer.

4.2 Results
4.21 Endometrial epithelium becomes a squamous, stratified epithelium in
Merlin mutant mice
After puberty, the endometrium forms an intricate architecture where
tubules branch off the main lumen and secondary branches form glandular
epithelium (Figure 1d)(20). Nf2eeKO (Nf2lox/lox; Wnt7a-Cre) and Nf2seeKO
(Nf2lox/lox; PR-Cre) mice do not form glands by P21 (Chapter 3) but how Merlin
deficiency affected the post-puberty endometrium is still not understood. Since
Nf2eeKO mice do not frequently survive past 2 months (Figure 10a), we utilized
the Nf2seeKO mice to examine how Merlin-deficiency affects endometrial
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Figure 10 Nf2seeKO mice uteri change after puberty to resemble a
decidualized uterus.
Survival curve of Nf2eeKO mice until 100 days when 100% of mice were lost (a).
Wild-type (b) and Nf2seeKO (c) mice at P21 show a loss of glands in Nf2seeKO
but no other visible phenotype. By 3 months of age, virgin Nf2seeKO exhibit an
abnormal morphology with a dense myometrium and stroma compared to wildtype mice (d-e). Gross morphology of the uteri shows a thick uterine horn in the
Nf2seeKO mice by 5 months compared to wild-type (f-g), however at 2 months
the horns look relatively normal (h). Wild-type (i) and Nf2seeKO (j) uteri and 3.5
days post coitus (DPC) look similar to Nf2seeKO uteri at 3 months (e).
Interestingly, Nf2seeKO uteri that have been serially mated have an exacerbated
morphology compared to Nf2seeKo at 3.5 DPC with a thick longitudinal
myometrium and thin radial myometrium (k).Quantification of the thickness of the
longitudinal myometrium in µm (l). Quantification of the thickness of the radial
myometrium in µm (l). *p<0.0033.
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homeostasis. It should be noted that the reason for death is not known, however,
it does not appear to be related to the endometrial phenotype. At P21, wild-type
mice have 8-10 endometrial glands on average within the endometrium (Figure
4a, f-g, Figure 10b), while Nf2seeKO mice do not form endometrial glands
(Figure 4g, Figure 10c). Interestingly, by 3 months of age the Nf2seeKO uteri
significantly changed showing a simpler luminal epithelium with a small ovular
lumen compared to wild-type endometrium (Figure 10d-e). Additionally, we saw a
denser stroma and a thicker myometrium than wild-type uteri (Figure 10d-e). The
gross morphology of mutant uteri show thickened and firm horns compared to
wild-type uteri at 5 months of age (Figure 10f-g). Around P60, we began to notice
a vagina with a dark brown coloring in the Nf2seeKO FRT that we continued to
observe in the older Nf2seeKO females (Figure 10g-h). Interestingly, the
Nf2seeKO mouse endometrial luminal epithelium is positive for keratin 14 (K14),
a squamous epithelial marker normally contained in the vaginal epithelium. Wildtype endometrial luminal epithelium is not positive for K14, therefore this may
indicate a possible cell fate change in the epithelium.
The aberrant histology of the Nf2seeKO aged uterus appeared similar to
an early pregnant uterus (3.5-5.5 days post coitus)(288). We became interested
in whether this histological phenotype usually observed during normal pregnancy
could be exacerbated following breeding. Wild-type female uteri at 3.5 DPC
(days post coitus) had a condensed endometrial stroma that looked similar to
decidua, the endometrial glands had decreased in size, and the endometrial
lumen was condensing into a smaller luminal structure (Figure 10i). Nf2seeKO
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female uteri at 3.5 DPC had a similar condensed endometrial stroma, especially
around the myometrium with a shrunken endometrial lumen in a circular shape
(Figure 10j). In addition, we observed serially mated Nf2seeKO females had an
exacerbated phenotype compared to post-puberty mutant or 3.5 DPC uteri
(Figure 10e, j, k). In fact, the radial myometrium was significantly thicker in the
serially mated Nf2seeKO females compared to the wild-type 3.5 DPC. However,
the longitudinal myometrium was not significantly different (Figure 10l-m). Since
pregnancy and puberty cause a change in hormonal cycling/changes in the
hypothalamic-pituitary-gonadal axis, we postulate that hormones may play a role
in this uterine phenotype.

4.22 Changes in endometrial epithelium coincide with changes in Wnt
signaling
In P7 mice, we observed a decrease in proliferation and no increase in
apoptosis (Figure 7). Therefore, we were interested to know what caused the
observed increase in cell density after puberty. Initially, we examined Hippo
signaling since Merlin is a negative regulator of Hippo, and Hippo signaling is
known to regulate organ size. We noted increases in both BIRC3 and CTGF in
Nf2seeKO mice at P60 (Figure 11a). Nf2eeKO mice after puberty also showed
an increase in CTGF but a decrease in BIRC3 (Figure 11e). In addition, since
canonical Wnt signaling mutants have previously been shown to affect
endometrial gland formation and to cause K14+ epithelium(46), we examined Wnt
signaling downstream targets, Cyclin D1 (Ccnd1) and Myc by qRT-PCR
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Figure 11 Expression of Hippo and Wnt signaling in Nf2eeKO, Nf2seeKO, and
Merlin-deficient primary cells.
Expression of the Hippo signaling downstream targets, BIRC3 and CTGF, in Nf2seeKO
(a), Nf2eeKO (e), and Merlin-deficient endometrial cells (Nf2KOcells, i). Expression of
Myc, a Wnt signaling downstream target, in Nf2seeKO (b), Nf2eeKO (f), and Nf2KOcells
(j). Quantification of mRNA expression in Ccnd1 in Nf2seeKO (c), Nf2eeKO (g), and
Nf2KOcells (k). Sox17 mRNA expression in Nf2seeKO (d), Nf2eeKO (h), and
Nf2KOcells (l). Stable normalized genes were used *P<0.05, **P<0.01, ***P<0.005
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(Figure 11b-c, f-g). Interestingly, in aged Nf2seeKO and Nf2eeKO mice, we
observed an increase in both Ccnd1 and Myc (Figure 11b-c, f-g). We also
examined the Wnt signaling negative regulator, Sox17, which was shown to
increase in P7 Nf2eeKO mice. In both Nf2eeKO and Nf2seeKO post-puberty
mice, we found a substantial decrease in Sox17 mRNA expression (Figure 11d,
h). Furthermore, when endometrial epithelium was isolated and put into culture,
we observed a similar change in mRNA expression of BIRC3, CTGF, Ccnd1,
Myc, and Sox17 (Figure 11i-l). This suggests that after puberty there is a switch
in Merlin null mice from loss of Wnt signaling to overexpression of Wnt signaling
that may be hormone related.

4.3 Summary
Merlin is necessary for fertility (Figure 4h-j) in female mice and is also
necessary for proper homeostasis of uterine tissues. Loss of Merlin causes an
abrupt change to all compartments within the uterus (myometrium, endometrial
stroma, and endometrial epithelium). Changes within all the tissues of the uterus
on an endometrial specific knockout is not necessarily surprising since past work
has shown that the endometrial epithelium communicates with both the stroma
and the myometrium(248, 266, 289). However, since a majority of Nf2eeKO
mice are not able to survive to 4 months, it is not clear if this is due to the
epithelium, or a combination of signaling from the stroma and epithelium.
The endometrial epithelium is fascinating because we observe a cell fate
change from K14- to K14+ tissue. This implies that loss of Merlin can cause a cell

97

fate change within epithelial cells. In addition, Wnt signaling appears to
significantly increase in the uterine tissue based on mRNA expression of
downstream targets. Both the Wnt7a and b-catenin conditional knockout mice
also show a change in endometrial epithelial architecture, however it is not
known whether canonical Wnt signaling changes in the older Wnt7a and bcatenin knockout females(46, 290). The increase observed in Ccnd1 and Myc
are also observed in primary cells isolated in culture. Since epithelial cells in
culture proliferate in order to reach confluency, this increase in Ccnd1 and Myc
are not unexpected and correlates with other data that shows mRNA expression
is upset quickly when primary endometrial epithelial cells are cultured. Since the
histological changes occur after puberty and are more pronounced in parous
females versus nulliparous females, we hypothesize that the changes in uterine
architecture and potentially the overexpression of Wnt signaling are related to
hormonal fluctuations. This study shows that Merlin loss affects both
development and homeostasis of the uterus and more work is necessary to
understand how Merlin affects the aging uterus.
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Chapter 5: Loss of polarity alters proliferation and differentiation in lowgrade endometrial cancers by disrupting Notch signaling
This chapter is based upon Williams, E., Villar-Prados, A., Broaddus, R.,
Gladden, A. (2017) Loss of polarity alters proliferation and differentiation in lowgrade endometrial cancers by disrupting Notch signaling. PLoS ONE 12 (12):
e0189081. https://doi.org/ 10.1371/journal.pone.0189081 is licensed under CC
BY (Creative Commons Attribution license) by PLoS One.

5.1 Introduction
Merlin has been shown to affect endometrial homeostasis and proper
polarity protein localization in the endometrial epithelium (Chapter 3-4). Polarity
genes are shown as being mutated, amplified or deleted in 37% of endometrial
adenocarcinomas in the TCGA database(164, 165). Alterations in members of
the Par complex accounts for 18% of these cancer cases(164, 165). These
members include Par3, aPKC, and Par6. In general, polarity complexes are
necessary for proper apical and basal membrane formation; this functionally is
dependent on the integrity/completeness of the complex. Accordingly,
dysregulation or disruption of any polarity gene or protein members can cause
mislocalization and dysfunction of all polarity proteins irrespective of mutation,
gene amplification, deletion, or epigenetic changes(103). Apicobasal polarity,
specifically the Par complex is known to be affected in a multitude of
cancers(138, 166, 184, 291). As previously discussed, Par3 loss causes an
increase in metastasis in some breast cancer mouse models(138). Conditional
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Par3 knockout in epidermal tissue causes an increase in melanoma and
hyperplasia of melanocytes when a skin carcinogen is applied(292). While Par3
has been shown to increase tumor formation and affect tumor progression, there
are few studies to understand how Par3 and the Par complex is involved in the
formation of tumors.
The Par complex is known to be necessary for proper
compartmentalization of membrane receptor signaling. For example, Notch
signaling requires Par3 for the asymmetric division of Notch in mouse radial glial
cells(81). In addition, Par complex regulators like Merlin are known to affect the
proper localization of transmembrane proteins like Notch(80). The correct
membrane localization of EGFR (epidermal growth factor receptor), a
transmembrane protein has been shown to be necessary for proper vulval
development in C. elegans(293). Another set of receptor tyrosine kinases,
FGFRs (fibroblast growth factor receptors) are known to localize to different
compartments within the same cell-type, thus localization of each may be
necessary for coordinating different signaling pathways within cells(294). The
Frizzled receptors involved in canonical Wnt signaling or planar cell polarity
localize to different areas of the membrane in the same cell-type(56). This
suggests that correct compartmentalization of receptors is necessary for proper
membrane-bound receptor signaling. Interestingly, while it is known that the
different Notch receptor extracellular domains determine the capability to localize
to the membrane and efficiency to be cleaved, it is not well understood how
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specific membrane localization of the receptors plays a role in Notch
signaling(77).
As discussed in Chapter 1, the canonical Notch signaling pathway has a
membrane-bound receptor and ligand that must interact for increased expression
of downstream targets. Notch signaling is hypothesized to function as a switch
causing different phenotypes depending on the overall level of NICD (Notch
intracellular domain). This feature is not dependent on the specific Notch
receptor being utilized(77, 79). While there is a basic understanding of Notch
signaling, it’s activity in a multitude of diseases like cancer, highlights the need to
further understand the Notch pathway.
Previous work has shown that Notch signaling can be tumor suppressive or
oncogenic in a cancer dependent manner(295–297). In the cervix, Notch
signaling appears to be tumor suppressive(72, 298, 299). In contrast, Notch is
upregulated in ovarian cancer, implying it is oncogenic. The role that Notch plays
in reproductive cancers is unclear and controversial(300). Interestingly, two
different conditional Notch1 activating mutants have been generated in the FRT
(Rosa26N1ICD/N1ICD; Amhr2-Cre [1], Rosa26N1ICD/N1ICD; PR-Cre [2])(26, 74). The
Amhr2 mutant drives overexpression of Notch1 in areas of the ovary, endometrial
stromal cells, and myometrium, while the PR mutant forces overexpression of
Notch1 in the entire endometrium, ovary, and oviduct(26, 74). The
Rosa26N1ICD/N1ICD; Amhr2-Cre mouse was found to have defects in the
architecture of the oviduct and cause cyst formation at around 3-4 months of age.
Similar to Nf2eeKO and Nf2seeKO mice, Rosa26N1ICD/N1ICD; PR-Cre mice do not
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form endometrial glands(26, 74). Both mutants were determined to be
infertile(26, 74). Whether these mice show similar decidual-like abnormalities as
the Nf2seeKO mice in the post-puberty uterine tissues is not known. It is possible
that the aglandular phenotype seen in both mice may be related to the disruption
of apicobasal polarity. Accordingly, we postulate that apicobasal polarity is critical
for proper endometrial maintenance, whereby its loss and dysregulation of Notch
signaling is involved in endometrial tumorigenesis.

5.2 Results
5.21 Loss of polarity, but not E-cadherin localization, in low-grade
endometrial cancer
Normal human endometrium consists of a single layer of polarized
glandular epithelium resting on the basement membrane and surrounded by
adjacent stromal cells(301). To determine the status of apicobasal polarity in
endometrial cancer (EC), we first examined the localization of the apical protein,
Ezrin and the apical polarity protein, Par3 in normal endometrium in relation to
the localization of adherens junction protein, E-cadherin. Both Par3 and Ezrin
localized to the apical side of the polarized glandular epithelium of normal
endometrium (Figure 12a, d). We next examined Ezrin and Par3 localization in
G1 EC and G2 EC samples. We observed a decreased apical localization of both
Par3 and Ezrin in glandular structures of the tumors compared to minimal
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Figure 12 Loss of apicobasal polarity occurs in low-grade endometrial cancer.
Human endometrial tissue (a, a’, d, d’, d”), normal; (b, b’, e, e’, e”) grade 1
endometrioid endometrial carcinoma, G1 EEC; and (c, c’, f, f’, f”) grade 2 endometrioid
endometrial carcinoma, G2 EEC stained with antibodies for the apical proteins (a-c)
Ezrin or (d-f) Par3, E-cadherin and DAPI. Scale bar, 20 μm. Asterisks indicate glandular
lumen and arrows show apical localizing protein (a’) Ezrin or (d’) Par3. Scale bar, 20
μm. (g and h) Quantification of (a-c) Ezrin or (d-f) Par3 apical localization in 10 lumens
of each sample (n = 3 normal, n = 2 G1 EEC, n = 2 G2 EEC) showing loss of apical
protein localization in low-grade EEC. Error bars represent SEM.
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changes in E-cadherin localization (Figure 12a- f, Figure 13a-c, e).
Quantification of the percentage of glandular epithelial cells with apical
localization of either Ezrin or Par3 shows nearly a four-fold decrease in ECs
compared to normal endometrium (Figure 12g-h). Additionally, the presence of
the apically localized differentiation marker acetylated tubulin, which marks
cilia(302–304), was decreased in G1 and G2 EC (Figure 13f-i). These data
indicate that apicobasal polarity is disrupted in low-grade endometrial tumors.
We previously demonstrated that establishment of apicobasal polarity in
developing epithelial tissue requires adherens junction (AJ) formation(122). Loss
of polarity is closely associated with advanced or metastatic tumors and
epithelial-to-mesenchymal transition (EMT), a transcriptional program that
downregulates the AJ protein, E-cadherin (305). To investigate E-cadherin
protein expression and localization in G1 and G2 ECs lacking apicobasal polarity,
we stained normal endometrium and ECs for E-cadherin. Interestingly, although
apicobasal polarity was disrupted, E-cadherin remained present and localized to
the basolateral membranes of glandular epithelial cells in G1 and G2 EC (Figure
13a-c, e). Subsequently in more advanced G3 EC, we see loss of E-cadherin
expression indicating loss of E-cadherin is a late event in EC (Figure 13d).
Overall, these data demonstrate that loss of apicobasal polarity, but not the AJ
marker E-cadherin, corresponds with decreased cellular differentiation in lowgrade endometrial tumors.
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Figure 13 E-cadherin localization and cilia presence in endometrial cancer with
disrupted polarity.
Normal endometrium (a, a’), G1 EEC (b, b’) and G2 EEC (c, c’) stained with an antibody
against E-cadherin and DAPI. Images of (a-c) E-cadherin staining showing localization
to the apical junctions and lateral border in normal endometrium, G1 EEC, and G2 EEC
(a’-c’). Asterisks indicate glandular lumen. G3 EEC stained with antibodies against Ecadherin (green) with DAPI (d) or with E-cadherin staining only (d’) showing loss of
localization to the apical junctions and lateral borders. Ratio of the apical localization of
Par3 to the basolateral localization of E-cadherin (e). Localization of Par3 or E-cadherin
was determined from 10 lumens of each sample (n = 3 normal, n = 4 EEC). Staining with
antibodies against acetylated tubulin (Ac. Tub), a maker of cilia, pan cytokeratin (Pan
Cyto.), an epithelial maker, and DAPI in normal endometrium (f), G1 EEC (g), and G2
EEC (h) shows a decrease in cilia indicative of decreased differentiation. Quantification
of the number of cilia found per gland determined from 10 lumens of each sample (i, n=3
normal, n=5 EEC). Error bars represent SEM. * <0.05. Scale bar, 20 μm
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5.22 Disruption of polarity in a 3D cell model phenocopies changes in
cellular differentiation observed in low-grade endometrial tumors.
To understand how apicobasal polarity was regulating differentiation we
utilized a commonly used polarized epithelial cell model, Madin-Darby Canine
Kidney (MDCK) cells, as we were unable to obtain normal endometrial epithelial
cells. Apicobasal polarity was disrupted through shRNA-mediated knockdown of
Par3, Ezrin or Merlin (Figure 14a-c). To better recapitulate the 3D organization of
the endometrium, we cultured Scramble-shRNA (Scr-shRNA), Par3-shRNA
(Par3 kd) and Ezrin-shRNA (Ezrin kd) cells in a 3D matrix and stained the cells
for acetylated tubulin, a marker of cilia and Phalloidin or E-cadherin and ZO-1
(Figure 14d-f, k-m). Scr-shRNA cells formed single lumen structures with
numerous cells extending cilia into the luminal space (Figure 14d, g-h).
Confirming previous studies, we observed Par3 kd, Ezrin kd, and Merlin-shRNA
(Nf2 kd) cells formed multi-lumen structures(134, 306) similar to what was
observed in human ECs (Figure 14e-h, not shown)(307). Additionally, we
observed an overall decrease in the presence of cilia in Par3 kd and Ezrin kd
analogous to our observations in endometrial cancer (Figure 14h). Both the
multi-lumen phenotype and the loss of cilia are indicative of a less differentiated
state in epithelial cells (302–304, 307–309), implying that disruption of apicobasal
polarity in the cell-based model caused a less differentiated state similar to ECs.
To provide additional evidence for altered differentiation in our Par3 kd
and Ezrin kd cell model, we examined the localization of the polarized tight
junction (TJ) marker ZO-1 and the formation of functional TJs, a known sign of
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Figure 14 Depletion of apical polarity proteins cause an increase in multiple lumen
structures and a decrease in differentiation markers in epithelial 3D cell culture.
Western blot analysis of (a) Par3, (b) Ezrin, and (c) Merlin knockdown in the MDCK cells
compared to a scramble control (a-c). Immunofluorescence staining on (d) ScrambleshRNA (Scr-shRNA), (e) Par3-shRNA (Par3 kd), and (f) Ezrin-shRNA (Ezrin kd) 3D
cysts for primary cilia by acetylated tubulin (ac. tub) and actin by Phalloidin (d-f). Scale
bar, 20 μm. Quantification of the (g) number of lumens (n = 2) and (h) cilia (n = 1)
present within all 3D cysts compared to scramble control cells. Par3 kd, Ezrin kd, and
Scr-shRNA had at least 49 cysts, 13 cysts, or 70 cysts examined per independent
experiment (g, h). Abnormal cilia include cysts without cilia present or cilia that appears
abnormal (h). Error bars represent SEM. Transepithelial resistance demonstrates loss of
functional TJ in Par3 kd and Ezrin kd cells compared to Scr-shRNA cells calculated by
Ohms per cm2 (i). Quantification of the number of BrdU positive cells in Scr-shRNA,
Par3 kd, and Ezrin kd cells (j). Orthogonal view of (k) scr-shRNA, (l) Ezrin kd, or (m)
Par3 kd with E-cadherin (green), ZO-1 (red), and DAPI showing multiple lumens in cysts
depleted of apical polarity proteins (k-m). Immunofluorescence staining for ZO-1 shows
altered TJ protein localization in Par3 kd and Ezrin kd cells indicative of decrease in
differentiation by loss of epithelial cell junctions (n-p). E-cadherin is also stained to label
junctional complexes. Scale bar, 20 μm. ZO-1 only staining to show the aggregation of
ZO-1 at tricellular junctions in white (n’-p’). Line plots of (n-p) showing intensity of Ecadherin (green line) and ZO-1 (red line) on the yellow line in the respective image, ScrshRNA (q), Par3 kd (r), and Ezrin kd (s). Note the overlap in E-cadherin and ZO-1
intensities in Scr-shRNA compared to distinct peaks of ZO-1 intensity in Par3 kd and
Ezrin kd indicative of mislocalized ZO-1 (q-s). Increased BrdU incorporation observed in
Par3 kd and Ezrin kd cell lines compared to the Scr-shRNA cells (j, t-v). BrdU only
staining (t’-v’). Scale bar, 20 μm. *P<0.05
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differentiation in MDCK cells(303). The Par3 kd and Ezrin kd cells displayed high
concentrations of ZO-1 at tricellular contacts; however, ZO-1 levels were low or
absent at other apical contact points (Figure 14n-p). Similarly, in 3D cultures ZO1 had a disorganized staining pattern in the Par3 kd and Ezrin kd cells compared
to control cells where it localized to the apical junctional border (Figure 14k-m).
Additionally, the Scr-shRNA cells show an increase in TER over time; by
contrast, the Par3 kd, as previously described (256), and Ezrin kd cell lines do
not increase TER to the same degree, that these cells are less differentiated and
cannot form a functional polarized TJ (Figure 14i). We also sought to determine
whether disruption of apicobasal polarity increased cell proliferation, another
marker of decreased cell differentiation. Cells depleted of either Par3 or Ezrin
displayed increased BrdU incorporation compared to the control cells (Figure 14j,
t-v). In concordance with our observations in low-grade endometrial cancer,
these data demonstrate that disruption of apicobasal polarity decreases
differentiation and increases proliferation of epithelial cells.

5.23 Disruption of apicobasal polarity decreases Notch signaling in
epithelial cells and in low-grade endometrial cancer.
To examine the underlying signaling pathways that could regulate differentiation
in cells with disrupted polarity we utilized our Scr-shRNA, Par3 kd, Ezrin kd, and
Nf2 kd cells. We examined Notch signaling as it regulates proliferation and
differentiation in a tissue-specific manner and in the normal endometrium(245,
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310–313). Notch signaling is tightly regulated during the menstrual cycle to assist
in increasing and decreasing proliferation and differentiation(245). Furthermore,
in Drosophila, Notch receptor localization is affected by Merlin which is known to
regulate polarity(80). Using qRT-PCR we found MDCK cells express Notch1 and
Notch2, and the Notch ligands, Jag1 and Jag2, along with several Notch targets
known to play a role in differentiation and proliferation including HEYL, HEY1,
and p21 (Figure 15a-c)(310–313). We observed a significant decrease in the
expression of Notch receptors, Notch ligands, and Notch downstream targets in
Par3 kd, Ezrin kd, and Nf2 kd cells indicating that altered apicobasal polarity
disrupts Notch signaling in this mammalian cell-based model (Figure 15d-x).
We next asked whether a similar change occurs in the Notch signaling
pathway in low-grade ECs. We performed qRT-PCR with normal endometrium,
G1, and G2 EC samples. We observed a significant decrease in the Notch
downstream targets, HEYL and HES1 and the Notch ligand, Jag1, indicating that
overall Notch signaling is decreased in low-grade EC (Figure 16d-f). Additionally,
we detected a significant decrease in the transcript levels of the Notch receptor,
Notch4 but no decrease in Notch1 or Notch2 (Figure 16a-c). Previous work has
demonstrated that overall levels of active Notch intracellular domain is critical for
downstream Notch signaling suggesting that Notch1 and/or Notch2 protein could
be regulated in other manners in low-grade EC(78, 314).
Our observation that Notch1 and Notch2 mRNA expression levels were
similar, but that downstream targets were significantly reduced, in EC compared
to normal samples, prompted us to examine the Notch1 and Notch2 proteins.
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Figure 15 Notch signaling decreases in Par3, Ezrin, and Merlin depleted epithelial
cells.
mRNA expression of Notch receptors (a), Notch ligands (b), and Notch downstream
targets (c) expressed in wild-type MDCK cells (a-c). qRT-PCR analysis of Notch1 (d-f),
Notch2 (g-i), JAG1 (j-l), JAG2 (m-o), p21 (p, s, v), HEYL (q, t, w), or HEY1 (r, u, x)
expression in Scr-shRNA, Par3 kd (d, g, j, m, p-r), Ezrin kd (e, h, k, n, s-v), and Nf2 kd
(f, i, l, o, v-x) cells. Samples were done in triplicate. Error bars signify SEM. * <0.05, **
<0.001, ***<0.0001
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Figure 16 Notch downstream signaling and receptor localization is disrupted in
low-grade endometrial cancer.
qRT-PCR of Notch receptors, ligands, and downstream targets in normal and in lowgrade (G1 & G2 EEC) endometrial cancer (a-f). The Notch receptor, Notch1 (a) and
Notch2 (b) show no change in expression while Notch4 (c) is decreased. Notch ligand
Jag1 (d) and downstream targets HEYL (e) and HES1 (f) are down regulated in lowgrade endometrial cancer. Notch1 (a) and Notch2 (b) data was analyzed using ΔCT with
the Tata box binding protein (DBP) as the reference gene with 7 samples for Normal, G1
EEC, and G2 EEC. Notch4 (c), Jag1 (d), HES1 (e), and HEYL (f) were analyzed by
calculating the number of molecules of the gene of interest compared to 18SrRNA (c-f,
%18SrRNA). Tukey box plots were used with SEM where + is the mean value and • are
outliers. Normal (n = 10), G1 EEC (n = 9), and G2 EEC (n = 22). Immunofluorescence of
Notch receptors showing localization of Notch1 (g-i, g’-i’) and Notch2 (j-l, j’-l’) in normal
endometrium (g, j), G1 EEC (h, k), and G2 EEC (i, l). E-cadherin marks the basolateral
cell:cell contacts (g-l). Asterisks signify the lumen. Scale bar, 20 μm. Images of (g-l) with
Notch1 or Notch2 respectively showing localization to the lumen (g’-l’). Arrows denote
lateral localization of Notch1 or Notch2.
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The Notch receptors are membrane-bound proteins whose activation may be
affected by subcellular localization(315). In normal human endometrium Notch1
and Notch2 localize to the basolateral and lateral membranes of the glandular
epithelial cells, respectively (Figure 16g, j). In low-grade ECs, by contrast, neither
Notch1 nor Notch2 receptor proteins localize correctly to the lateral membrane of
epithelial cells (Figure 16g-l). Moreover, Notch1 and Notch2 protein levels are
decreased in the tumor. Collectively, these data show that low-grade ECs have
disrupted apicobasal polarity and mislocalized and/or reduced protein levels of
Notch1 and Notch2 receptors that may lead to the overall decrease observed in
Notch downstream targets.

5.24 Expression of Par3 in endometrial cancer cells promotes
differentiation and decreased proliferation.
To determine whether establishment of apicobasal polarity alters
differentiation or proliferation in endometrial cancer, we assayed endometrial
cancer cell lines for changes in apical polarity proteins. We examined Par3
expression in a panel of endometrial cancer cell lines from G1, G2, and G3
tumors(316). Western blot analysis revealed that Par3 was not readily detected
in a majority of the endometrial cancer cell lines (Figure 17a). Not surprisingly
since many of the cancer cell lines are well differentiated, detectable levels of Ecadherin were observed (Figure 17a). To determine how tumor cells would
respond to Par3 expression, we overexpressed Par3 in Ishikawa and HEC-1-A
cells (Figure 17b-c).
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Figure 17 Expressing Par3 in endometrial cancer cell lines cause differentiation
phenotypes.
Western blot analysis of a panel of endometrial cancer cell lines (HEC-1-B, HEC-1-A,
Ishikawa, ECC-1, HEC-50, MFE-280, and MFE-296) for Par3 and E-cadherin (a).
Ishikawa and ECC-1 are well-differentiated cell lines, HEC-1-A, HEC-1-B, MFE-296 are
moderately differentiated cell lines, and HEC-50, MFE-280 are poorly differentiated cell
lines (a). Western blot analysis of Par3 in control transfection (control) and Myc-Par3
overexpression in Hec-1-A (b) and Ishikawa (c) cells (b-c). Parental (d, f) or exogenous
Par3 (e, g) in HEC-1-A (d-e) or Ishikawa (f-g) cells stained with ZO-1 (red), Myc (green),
and DAPI (d-g). Scale bar, 20 μM. ZO-1 only staining (d’-g’). Z-plane showing ZO-1,
Myc and/or DAPI staining (d”-g”, d”’-g”’, d””-g””). Quantification of disorganized ZO-1
in the parental (n = 3) and Par3 overexpression HEC-1-A cells (n = 3) for at least three
regions of interest (ROI) per experiment (h). Error bars represent. SEM **<0.01.
Quantification of disorganized ZO-1 in the parental (n = 3) and Par3 overexpression
Ishikawa cells (n = 3) for at least three regions of interest (ROI) per experiment (i). Error
bars represent. SEM *<0.05.
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In contrast to parental cells lacking Par3, in which the TJ protein ZO-1 did
not localize to apical cell contacts in an organized pattern, we observed a more
fence-like organization of ZO-1 in cells overexpressing Par3 (Figure 17d-i).
These data are concordant with our previous observations indicating Par3 loss
causes decreased differentiation in MDCK cells (Figure 14n-s). In addition, cells
ectopically expressing Par3 showed lower levels of proliferation than in the
parental endometrial tumor cell lines lacking Par3, as visualized by BrdU
incorporation (Figure 18a-f). Finally, cells expressing exogenous Par3 showed an
increase in Notch1 localization to cell:cell contacts compared to cytoplasmic
Notch1 localization in parental cells with reduced levels of Par3 (Figure 18g-h).
Interestingly, HES-1 (a Notch downstream target) also trended toward an
increase in both Par3 overexpression cell lines (Figure 19a,d). These data
provide evidence that expression and apical localization of Par3 is critical for the
proper differentiation of the endometrial epithelium cells, and that disruption of
apicobasal polarity affects the ability of endometrial epithelium to regulate
differentiation, proliferation, and Notch receptor localization (Figure 18i).

5.25 Decreases in proliferation and migration observed in Par3
overexpressing cells is due to Notch signaling.
Increased migration is a hallmark of cancer cells in culture, we examined
migration in the endometrial cancer cell lines in the presence or absence of Par3.
Par3 overexpression was found to decrease the distance HEC-1-A cells moved
(Figure 19b, g-j). In addition, a similar trend was observed in Ishikawa cells,
where Par3 overexpression decreased the distance that cells traveled
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Figure 18 Expressing Par3 in endometrial cancer cell lines blocks proliferation.
Staining of parental (a, c) and Par3 overexpressing (b, d) Hec-1-A (a-b) and Ishikawa
(c-d) cells for Par3, BrdU, and DAPI (a-d). Scale bar, 20 μM. BrdU only staining (a’-d’).
Quantification of BrdU incorporation in the parental (n = 3) and Par3 overexpression (n =
3) in HEC-1-A (e) and Ishikawa (f) cells for at least three ROI per experiment. Error bars
represent. SEM *<0.05. ***<0.001. Parental HEC-1-A (g) or HEC-1-A with exogenous
Par3 (h) stained with DAPI and Notch1 (g-h). Schematic of proposed model for how
apicobasal polarity controls differentiation of endometrial epithelial cells by regulating
Notch receptor localization and, Notch downstream targets that modulate proliferation
and differentiation (i).
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(Figure 19e, k-n). To determine if the changes to proliferation and migration were
related to Notch signaling, we utilized the g-secretase inhibitor DAPT (N-[N-(3,5Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester). Parental and Par3
overexpressing HEC-1-A and Ishikawa cells were treated with DAPT. HES-1
mRNA levels confirmed Notch signaling was inhibited when either parental or
Par3 overexpression cells were treated (Figure 19a,d). The amount of distance
traveled was measured and it was determined Par3 expressing cells treated with
DAPT had similar amounts of migration as either HEC-1-A or Ishikawa parental
cell lines respectively treated with DAPT (Figure 19b, e, g-n). Additionally, BrdU
incorporation was shown to be similar between parental cell lines and Par3
overexpression cell lines when treated with DAPT (Figure 19c, f, o-r). These
results demonstrate that Par3 expression increases Notch signaling in
endometrial cancer cell lines resulting in decreased proliferation and migration.

5.26 PTEN loss decreases the effectiveness of Par3 expression in
endometrial cancer cells
PTEN (phosphatase and tensin homolog) is mutated in at least 50% of
low-grade endometrial cancer cases, with 75% of cases showing protein
loss(196). This indicates inactivation of PTEN can occur through either genomic
mutation or post-translational mechanisms and deletion of PTEN can cause
endometrial cancer in vivo(36, 196). PTEN is known as a negative regulator of
the PI3K (Phosphoinositide 3-kinase) signaling pathway by converting the
membrane lipid PIP3 (phosphatidylinositol (3,4,5)-triphosphate) to PIP2
(phosphatidylinositol (3,4,5)-biphosphate as previously discussed in Chapter 1
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Figure 19 Inhibiting Notch signaling rescues Par3 mediated changes in migration
and proliferation.
qRT-PCR analysis of the Notch target HES-1 in parental, Par3 overexpression and
DAPT treated HEC-1-A (a) and Ishikawa (d) cells (a, d). Quantification of cell migration
for HEC-1-A (b) and Ishikawa (e) parental, Par3 overexpression, and cells treated with
the g-secretase inhibitor (DAPT) to block Notch signaling (b, e). Quantification of BrdU
incorporation in the parental, Par3 overexpression, and DAPT treated HEC-1-A (c) and
Ishikawa (f) cells (c-f). Images showing the start and end of migration assays performed
to examine rate of migration for HEC-1-A (g-j, g’-j’) and Ishikawa (k-n, k’-n’) parental
cells (g, k), Par3 expression cells (h, l), and cells treated with DAPT (i-j, m-n).
Immunofluorescent analysis of BrdU incorporation in HEC-1-A or Ishikawa parental cells
treated with DAPT (o, q, o’, q’) or Par3 expressing cells treated with DAPT (p, r, p’, r’).
Top panels (o-r) show BrdU (green) with DAPI (blue) staining and panels (o’-r’) show
BrdU staining alone. Scale bar, 20 μM.*P<0.05, ***P<0.0001.
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(Figure 20a)(317). PIP3 is necessary for proper formation of the basal membrane
and PIP2 is found at the apical membrane in epithelium (Figure 20a)(193, 318).
PTEN is also important for proper apical protein localization and is necessary for
the formation of the apical membrane in epithelial cells(132). In fact, PTEN binds
Par3 on the third PDZ binding domain (Figure 20b)(127, 131). It has been
hypothesized that PTEN is able to assist in apicobasal polarity establishment
through actin organization or apical protein localization(127, 131).
Since PTEN is inactivated in a majority of low-grade endometrial cancers,
we examined PTEN protein in the panel of seven endometrial cancer cell lines
previously examined for Par3 (Figure 17a, Figure 20c). We observed that many
of the cell lines had low levels of PTEN including Ishikawa cells. In order to
understand what role PTEN plays, we compared the phenotypes between the
Ishikawa Par3 expression cell line and two cell lines containing PTEN: HEC-1-A
and MFE-280 Par3 expression cell lines (Figure 20a). Initial observations showed
that HEC-1-A cells had a more pronounced decrease in proliferation and the
MFE-280 cells even showed a change from a multi-layer epithelial sheet to
monolayer or bilayer epithelial sheet (Figure 18a-d, Figure 20d-e). Notch1
localization to the membrane increases in both Ishikawa and HEC-1-A cell lines
when Par3 is expressed, however, it was more evident in the HEC-1-A Par3
expression cell lines (Figure 16g-h, Figure 20f-g). Ishikawa Par3 expressing cells
reacted more to DAPT, the Notch signaling inhibitor, then HEC-1-A Par3
expressing cells in terms of proliferation and changes in HES-1 expression
(Figure 19a, c-d, f, o-r).
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Figure 20 The role of tumor suppressor PTEN in Par3-depletion phenotypes.
PI3K (Phosphoinositide 3-kinase) signaling consists of PTEN converting PIP3 to PIP2
and PI3K converting PIP2 to PIP3(a)(317). PIP3 causes activation of AKT (protein kinase
B) which leads to inhibition of apoptosis and increases in cell growth (a). PIP2 localizes
to the apical membrane while PIP3 is involved in basal membrane formation (a)(193,
318). Par3 binding partners include Par6, Numb, Kif3a, and PTEN (b). Western blot
analysis of PTEN in seven endometrial cancer cell lines including HEC-1-B, HEC-1-A,
Ishikawa, ECC-1, HEC-50, MFE-280, and MFE-296 (c). XZ-plane images of E-cadherin,
ZO-1, and DAPI in MFE-280 parental (d) and Par3 overexpression (e) cells. Parental
Ishikawa cells (f) or Ishikawa cells with exogenous Par3 (g) stained with DAPI and
Notch1 (f-g). Quantification of invasion in ECs categorized by PTEN mutations, polarity
mutations, or a combination of the two (h). Percentage of ECs by stage that have PTEN
mutations, polarity mutations or a combination of the two (i). Quantification of the age of
patients with PTEN mutations, polarity mutations, or a combination of the two (j).
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Figure 20g)(164, 165). In addition, lower FIGO stage tumors have high amounts
of polarity and PTEN mutations (Figure 20h)(164, 165). Finally, the age of
patients diagnosed with endometrial cancer trended toward a decrease with
polarity mutations with or without PTEN mutations in combination (Figure
20i)(164, 165). This points toward polarity potentially being involved in the lowgrade or initial stages of endometrial cancer in addition to inactivation of PTEN.

5.3 Summary
From previous chapters, we found that Merlin regulates apicobasal
polarity in the endometrium and is necessary for proper endometrial
homeostasis. Polarity is frequently disrupted in epithelial cancers including
endometrial cancer. We determined that similar to the Nf2eeKO mice, polarity
was disrupted in early stage endometrial cancers, while E-cadherin exhibited
relatively normal staining, demonstrating that cell polarity and cell adhesion can
be exclusively affected. In order to understand how polarity was affecting the
underlying biology of endometrial cancer, we utilized both canine kidney (MDCK)
cells in three-dimensional cultures and endometrial cancer cell lines. Par3 loss in
MDCK cells caused a multi-lumen phenotype similar to low-grade endometrial
cancers. To understand what was causing an increase in proliferation in the
MDCK cells without Par3, we examined a signaling pathway known to be
affected by polarity proteins and regulated during menstruation, Notch
signaling(81, 245). Par3, Ezrin, and Merlin knockdown in MDCK cells showed a
decrease in Notch signaling downstream targets.
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In addition, many endometrial cancer cell lines have low levels of Par3
protein. When Par3 is expressed in these cell lines, proliferation and migration
decreases, potentially in a PTEN-dependent manner. Since Notch signaling was
downregulated in the MDCK cells depleted of Par3, we examined Notch
downstream targets in the endometrial cancer cell lines. We found there was a
trend of HES-1 increasing in the Par3 expressing cells compared with the
parental control cells. In order to confirm that Notch signaling played a role in
proliferation and migration, we utilized a g-secretase inhibitor and observed an
increase in proliferation and migration, similar to parental cells treated with the
inhibitor. This indicates that Notch signaling is involved in the changes in
proliferation and migration. Interestingly, a Notch mutant mouse causes a similar
phenotype as to what we observe in our Nf2seeKO and Nf2eeKO mice
potentially showing that Notch is also important when polarity is disrupted in the
endometrium(26). All together this data strongly suggests that polarity is
necessary for proper membrane-bound Notch receptor signaling and tissue
homeostasis in the endometrium; and the dysregulation of the Par complex early
in endometrial cancers is involved in the progression of these tumors.
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Chapter 6: Conclusions, Discussion, and Future Directions

6.1 Conclusions and Discussion
Apicobasal polarity is known to be necessary for the asymmetric division
of a one-cell embryo and proper development and homeostasis of epithelial
tissues(72, 124, 139). Polarity has been noted to change during implantation of a
blastocyst, but otherwise has not been examined within the endometrium. The
endometrium is a complex organ that goes through two different types of
tubulogenesis: Mullerian duct formation and endometrial gland development.
Recognizing how polarity is involved in the endometrium can help us understand
infertility, uterine diseases, and proper endometrial development. This
dissertation delves into how the uterus utilizes apicobasal polarity and the
polarity regulator, Merlin, to properly develop and function.
Merlin heterozygous female mice have a decreased litter size(219),
however, before this dissertation it was not well understood why. We show that a
conditional deletion of Merlin in the endometrium causes a loss of endometrial
glands and disruption of apicobasal polarity on the luminal epithelium. The
subfertility phenotype observed in Nf2-/+ female mice may be caused by a loss of
heterzygosity within some regions of the endometrium, affecting the number of
endometrial glands. The affect that Merlin has on endometrial glands is not
completely unexpected since Merlin has been shown previously to be involved in
renal tubule proliferation and hair follicle formation(225, 238).
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The loss of Merlin in the endometrium both embryonically (Wnt7a-Cre)
and postnatally (PR-Cre) caused the loss of endometrial glands indicating the
loss of glands is not due to defects in Mullerian duct formation. Additionally,
through the two conditional Merlin knockouts, we have shown that Merlin deletion
in the epithelium specifically causes the aglandular phenotype. Endometrial
gland loss was accompanied by loss of FoxA2 and Sox9 nuclear expression in a
majority of the endometrial epithelium. While most cells did lose FoxA2 and Sox9
there was a small subset of luminal epithelium that exhibited nuclear staining of
these transcription factors. Muc1 staining also showed discrete areas that were
similar in intensity to wild-type endometrial glands. Nf2seeKO (Nf2lox/lox; PR-Cre)
mice are infertile, implying that the luminal epithelium that is positive for glandular
markers may not fully function as glands. These results suggest that Merlindeficient luminal epithelium is able to turn on some glandular transcription factors
but is unable to properly form glandular architecture or function as glands.
If this is the case then we would expect proliferation, apoptosis, or cell
movement/tension to change within the forming endometrial glands. Proliferation
and apoptosis were examined to find minimal changes to the luminal epithelium
at an early developmental stage suggesting that another area must be defective
in gland formation. In order for the luminal epithelium to involute and form the
glandular epithelium, changes in mechanical stress must occur allowing the
initiation of the budding glandular structure. Tension markers were examined in
Merlin-deficient tissue to show that an accumulation of Vinculin, Myosin IIB, and
pMLC were observed at the basal membrane. Interestingly, the distribution of
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cell:cell versus cell:extracellular matrix adhesion angles were also skewed
between wild-type and Merlin-deficient tissue indicating disorganization of the
luminal epithelium leading to stretching of the epithelial basal surface. We
postulated that this change in basal membrane tension and angle distribution is
related to the formation of a contractile actin ring at the apical lumen. When
examined, we found a significant increase in intensity of the actin staining on the
apical surface of the Merlin-deficient tissues. The increase in actin intensity was
not only present at early stages like P7 but persisted and intensified by P21.
Merlin is important in F-actin stabilization and loss of Merlin causes increased
apical constriction in other epithelium(232, 319). This may indicate that the
changes in transcription factors in the Merlin mutant could be caused by the
increased apical constriction and changes in cellular tension.
A recent study demonstrated that the Hippo and Wnt pathway are involved
in the response a cell has to tension(284). Nuclear b-catenin increased with
strain in mammalian cells in a cadherin-dependent manner(284). Wnt signaling is
also necessary in endometrial gland development(35, 46). Since b-catenin
staining looked similar between wild-type and Merlin-deficient tissue, we utilized
qRT-PCR to examine mRNA expression of Wnt downstream targets. We
determined that Myc, a Wnt signaling downstream target, was significantly
decreased. There was also a slight decrease in Sox9 mRNA expression.
However, Wnt signaling downstream targets can be regulated in a tissue specific
fashion and other Wnt downstream targets like Axin2 and Cyclin D1 were
upregulated in P7 tissue. Conditional loss of Merlin in other epithelium causes
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changes to EGFR (Epidermal Growth Factor Receptor) internalization increasing
the amount of EGFR signaling(232). Potentially the increase observed in Cyclin
D1 is related to EGFR signaling since Cyclin D1 has also been observed
downstream of the EGFR pathway(320). Interestingly, Sox17, a Wnt signaling
negative regulator, was significantly higher in Nf2eeKO (Nf2lox/lox; Wnt7a-Cre)
mice then wild-type mice at P7. This could indicate that Merlin regulates Wnt
signaling through Sox17. Since Merlin and ERM proteins are known to regulate
the apical junctions and the actin cytoskeleton, potentially the increased Pcadherin levels in the mutant endometrium causes the increase in Sox17
because other cadherins have been shown to affect the amount of Sox17 in the
endoderm(283). Whether the changes to Wnt signaling or the changes to tension
cause the aglandular phenotype observed in both Nf2eeKO and Nf2seeKO mice
are not understood. However, unlike most Wnt signaling mouse mutants(4, 25,
290), Nf2eeKO and Nf2seeKO have discrete patches of luminal epithelium that
appear to function like wild-type glandular epithelium. This indicates that
potentially Wnt signaling is secondary to the effects of tension and in fact the
inability to form glandular architecture is due to changes in the cytoskeleton of
the epithelium.
Loss of Merlin also causes a loss of polarized endometrial epithelium. This
loss of polarity may be what promotes the tension-mediated aglandular
phenotype. Polarity has previously been shown to be important in proper
tubulogenesis(321). Even more importantly, loss of polarity, specifically the Par
complex can cause apical constriction in epithelium(322). In Drosophila, dPar3
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(Bazooka) deletion caused apical constriction pulses to persist longer than wildtype Drosophila(323). While in mammalian cell culture, loss of Par3 with
mislocalization of aPKC caused an increase in ROCKs (Rho-associated kinases)
mediated apical constriction(322). Thus the loss of Merlin causing mislocalization
of Par3 and aPKC may cause the increased apical actin constriction and loss of
gland formation(122).
Since polarity is necessary for the proper implantation of a blastocyst in
the female uterus, we can postulate that even if endometrial glands were able to
form, Merlin-deficient females would have decreased fertility. In addition, there is
not a significant change to YAP nuclear localization between wild-type and
mutant tissue, suggesting this aglandular phenotype could be independent of
Hippo signaling. Since Wnt signaling is known to be involved in gland formation
and is affected in our Merlin-deficient mice, Wnt signaling could be critical for the
loss of glands.
The decrease in Wnt signaling in Nf2eeKO mice at P7 may be regulated
by the role Merlin plays in cell junction maturation (Figure 3d). Since Merlin is
necessary for the proper formation of adherens junctions, potentially the loss of
Merlin causes an increase in the cytoplasmic pool of a-catenin. a-catenin has
been shown to interact with APC and increase the propensity for b-catenin to be
phosphorylated and degraded(51). With larger amounts of cytoplasmic a-catenin,
there would be potentially more of an opportunity for APC to phosphorylate bcatenin and in doing so decrease canonical Wnt signaling causing the
downregulation of Myc and Sox9 observed.
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While both Nf2eeKO and Nf2seeKO mice showed a similar phenotype,
there were slight differences between Nf2eeKO and Nf2seeKO mice by P21.
This could indicate that Merlin depletion in the stroma does cause an effect on
the endometrium, however a stromal specific knockout of Merlin will better
identify the individual roles of the epithelium and the stroma. One noted
difference was that the myometrial density was more similar to wild-type mice in
the Nf2seeKO mice than the Nf2eeKO mice (Figure 5o-p). In addition, Muc1
staining was more intense in the Nf2eeKO luminal epithelium compared to the
Nf2seeKO epithelium (Figure 5d-f). Interestingly, a subset of the Nf2eeKO mice,
but not the Nf2seeKO mice, exhibit a dual endometrium phenotype (Figure 21ac). Since Wnt7a-Cre is expressed during Mullerian duct formation, this may be
caused by a loss of polarized migration before PR-Cre is active, however this has
not been examined in detail.
While the majority of Nf2eeKO mice were unable to survive past 2 months
(Figure 10a), Nf2seeKO were viable and we were able to perform a fecundity
study to examine if they were fertile. The fecundity study showed that Nf2seeKO
mice are infertile. Since the phenotype in the early Nf2eeKO and Nf2seeKO mice
are similar, we postulate that Nf2eeKO mice are also infertile. It should be noted
that the death of Nf2eeKO mice is not thought to be related to loss of Merlin in
the uterus but rather one of the other tissues (lung, neurons, etc) that Merlin is
deleted in the Nf2eeKO mice.
Additionally, in the 4-month-old Nf2seeKO mice, we observed a gross
morphology and histological change from wild-type mice. Some endometrial
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Figure 21 Nf2eeKO mice has a double endometrium phenotype that Nf2seeKO
mice do not.
Wild-type (a) and Nf2eeKO (b) mice at P21 display a multi-lumen phenotype where 3
mice out of 10 mice have a double endometrium (c).
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epithelium was found to have vaginal markers (K14+) and the luminal epithelium
was condensed to a small ovular lumen. This change in the lumen may be
related to the increase in F-actin at the apical surface observed in younger
female mice (P7 and P21). Interestingly, the Nf2seeKO uteri look very similar to a
wild-type decidualized uterus between E3.5-E5.5(288). The phenotype appeared
to worsen over time where the gross morphology of the uterus was drastically
more inflamed by 5 months of age. This change in gross morphology between
the wild-type and Nf2seeKO uteri were not observed in the few Nf2eeKO uteri we
were able to obtain. The phenotype was also exacerbated if the female was
mated. This implies that hormonal signaling may be related to the change in the
uterine tissue. However, more work is needed to confirm this. Most mouse
models that affect decidualization, cause a lack of a decidual reaction or an
inability to remodel the tissue after decidualization. Thus, if this tissue is
confirmed to be decidua, this would be one of the first mutants that acquires a
decidual response without a stimulus.
The 3-6 month old Nf2seeKO mouse also looks similar to a young female
rat uterus in diestrus with a smaller ovular lumen(324). As female mice age, they
eventually become acyclic(324, 325). One form of an acyclic uterus is persistent
anestrus which also shows similarities to the small ovular luminal epithelium in 36 month old Nf2seeKO mutants, though it is normally only seen after 14 months
of age in mice(324, 325). Thus, Merlin loss in the mouse endometrium may be an
accelerated aging phenotype not previously described well in mice.
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While we were surprised that the Nf2seeKO mouse model did not develop
cancer at 6 months of age, the mouse model did have a cell fate change and
abnormal gross morphology of the uterus suggesting it may still develop cancer.
There are multiple endometrial hyperplasia and cancer mouse models that do not
show malignancies until 10-12 months of age(22, 326). Thus, potentially the
Nf2seeKO mice need to age to at least 10 months in order for hyperplasia to be
visible. In the E-cadherin null uterus endometrial cancer is also not observed
except when they mutate p53 in addition to deleting E-cadherin(45). This may
also be an indication that Nf2seeKO mice must accrue other driver mutations
with Merlin to drive tumorigenesis. A similar phenotype is observed in a Par3 skin
knockout model where an increase in tumorigenesis is only observed when a
carcinogen is applied(137).
Merlin is genetically altered in 5% of endometrial cancer cases(164, 165).
Polarity genes including those regulated by Merlin are modified in 35% of
endometrial cancer cases(164, 165). Interestingly, Par3, a protein directly
regulated by Merlin is mislocalized in low-grade endometrial tumors. We found
another apical protein, Ezrin, was disrupted in low-grade endometrial cancer.
Controversially, one paper determined that Ezrin was not expressed in normal
endometrial glands and increased in endometrial cancer, however our work and
others work refutes this(200, 202). Since the formation of the apical junctions is
necessary for proper apicobasal polarity establishment, we examined whether
the apical junctions were also affected in low-grade endometrial cancer. Similar
to the Nf2eeKO and Nf2seeKO mice, the adherens junction protein, E-cadherin,
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still localizes properly in low-grade human endometrial cancer samples. This
indicates adherens junctions are properly formed, however we were unable to tell
whether the junctions are functional. Apicobasal polarity disruption without cell
adhesion loss appears to be tissue specific, since it has been documented in
many cancer cases that cell adhesion loss is linked to the disruption of
apicobasal polarity. But our work and a few other labs have shown that cell
adhesion may be maintained even when polarity is lost(72, 138, 327).
Previous studies have shown that disruption of polarity proteins like Par3
increase metastasis and late tumor progression(138), but our data indicates that
polarity is lost in low-grade samples where metastasis is not common. This
implies that polarity may be involved in tumor initiation or early tumor
progression. In order to examine whether polarity actually contributes to early
tumor formation or progression, we examined Par3 overexpression in
endometrial cancer cells and Par3 knockdown in MDCK cells. We determined
that Par3 regulates proliferation and migration in these cell lines through Notch
signaling suggesting that Par3 is involved in tumor development.
Notch signaling is known to be tumor suppressive and oncogenic in different
tissues. We confirm that Notch signaling is tumor suppressive within the
endometrium(72, 73). Utilizing a Notch signaling inhibitor, we establish that Notch
signaling plays a role in Par3-regulated cell proliferation and migration in
endometrial cancer cells. Based on Notch receptor localization data, we
postulate polarity is critical for proper membrane partitioning of Notch receptors
in the endometrium. This suggests that when polarity is lost, Notch receptors
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mislocalize causing aberrant Notch activation since both the Notch receptor and
ligand are membrane bound proteins. It may be noted that HES-1 was not
comparably increased in the Par3 overexpression endometrial cancer cell lines
as the decrease observed in Par3 knockdown MDCK cell lines. Both HEC-1-A
and Ishikawa cells are not only from individual tumors but also have been in
culture for more than a decade, invariably causing new mutations and expression
changes. Potentially these cell lines required more than just Par3 expression to
increase Notch signaling. In addition, we are unclear whether polarity loss can
only facilitate cancer progression, in the presence of another mutation.
PTEN is mutated in 50-80% of Type I ECs(71) and is known to be involved in
cell polarity(130). In addition, PTEN has been shown to be lost in some tumors
where it is not mutated(196). PTEN and AKT signaling are also linked to aberrant
Notch signaling in prostate cancer(296, 328), so potentially there is a cooperation
between PTEN, polarity and Notch signaling in EC. Moreover, when PTEN and
polarity genes are genetically altered, there is a trend toward a decrease in
cancer patients age and an increase in tumor invasion(164, 165). Thus, it is not
unfeasible that PTEN may facilitate tumor progression and utilize polarity
disruption to do so. Interestingly, in some endometrial cancer cell lines, those
with PTEN and Par3 expression, caused the cells to form a bilayer or monolayer
instead of a 4-5 multilayer cell sheet. These Par3 and PTEN expression cancer
cell lines may be differentiating since in culture some differentiated mammalian
epithelial cells form monolayers and localize ZO-1 to the apical junction.
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Interestingly, PTEN, adhesion, and polarity proteins including Par3 have also
been shown to have non-autonomous cell functions(246, 292, 329). This data
along with the data from Chapter 5 implies that cell intrinsic changes in polarity,
PTEN, and even adherens junction-mediated adhesion can be conveyed over a
local area of the tissue (246, 292, 329). This is useful when looking at this
research as a novel therapeutic approach. In fact, within the endometrial cancer
cell line data, we noted that cells that had low to no Par3 present also exhibited
decreases in proliferation and increases in tight junction protein localization. This
indicates that if polarity is disrupted in a small subset of cells, there may be
profound effect on the entire area, making it an interesting model for endometrial
tumorigenesis. In addition, potentially finding a targeted approach to polarize a
portion of the endometrial malignant epithelium may in fact help the entire
endometrium, making this an ideal treatment strategy.
The Merlin-deficient mouse models and our endometrial cancer data both
show a disruption of apicobasal polarity. In addition, Notch receptors increase
membrane localization in Par3 expressing endometrial cancer cell lines. We
postulated that the affect polarity has on Notch signaling is mediated through
proper membrane compartmentalization of the Notch receptors. Notch mutant
mice also cause an aglandular phenotype similar to the Merlin-deficient mice(26).
In addition, both mice show increases in glandular marker, FoxA2, on the
endometrial luminal epithelium(26). Merlin loss in the endometrium also causes
downregulation of Wnt signaling. Wnt signaling has also been shown to be
affected by the proper localization of the Wnt receptors (Frizzleds)(56).
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Potentially, the conditional Merlin knockout mouse causes mislocalization of
multiple membrane-bound receptors producing misregulation of different
signaling pathways including Wnt and Notch leading to the aglandular phenotype
observed.

6.11 Overall Conclusions
This work highlights the dynamic nature of endometrial tissue both during
development and homeostasis. Moreover, it implies that the proper regulation of
apicobasal polarity is necessary for normal development of endometrial glands
and for correct endometrial reorganization. This dissertation provides evidence
that Merlin plays a role in female fertility and potentially that Neurofibromatosis
Type 2 patients should work with genetic counselors for infertility, however inhuman data is necessary to confirm this. In addition, this data alludes to a role for
Merlin and apicobasal polarity within the aging of the endometrium and
endometrial cancer (Figure 22). Figure 22 summarizes the findings of this
dissertation. Overall this dissertation reveals novel results that may assist in
future therapeutic approaches for female infertility and endometrial cancer.
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Figure 22 Summary of Dissertation Findings
A wild-type endometrium forms glands around Postnatal day 5 (P5) that are fully formed
by P21 (a). In a Merlin-deficient endometrium, apicobasal polarity is disrupted. In
addition, basal membrane tension and apical contractile actin, may cause an increase in
Wnt signaling since Wnt is known to react to changes in tension (b). Additionally, since
Merlin is known to regulate apical junction maturation, the decrease in Wnt signaling
may be related to a large cytoplasmic a-catenin pool (b). a-catenin group b-catenin in
the presence of APC leading to b-catenin degradation(51). When polarity is lost during
endometrial homeostasis this causes a mislocalization of Notch receptors which leads to
decreases of Notch signaling and increases in epithelial proliferation and migration (c).
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6.2 Future Directions
The endometrial cancer work within this dissertation found that apicobasal
polarity affects cell migration and proliferation through Notch signaling. However, it
would be interesting to examine how Notch receptor overexpression and knockdown
cell lines differed or were similar to the Par3 overexpression cell lines. It would also
solidify the data to examine how an extracellular membrane mutation that causes
mislocalization on the Notch receptor genes affects cell migration and proliferation.
In order to understand whether there is cooperation between polarity and PTEN in
endometrial cancer, we would like to examine PTEN overexpression and knockdown
in the Par3 overexpression cancer cell lines. This will help us determine whether
PTEN loss increases cell proliferation, migration, and differentiation.
In addition, we would like to examine if Par3 affects the endometrial cancer cells,
non-cell autonomously. In order to do this, we need to generate an inducible Par3
overexpression cell line and co-culture them with parental cells to determine if the
parental cells also show a decrease in proliferation and migration. Ideally, utilizing
endometrial cancer mouse models, Par3 expression or Notch expression can be
examined as a potential endometrial cancer therapeutic. Future studies examining
how apicobasal polarity and/or downstream signaling pathways can be manipulated
in dynamic tissues such as the endometrium could lead to better therapeutic
strategies for patients with endometrial cancer. This work can improve the overall
health of endometrial cancer patients and help with quality of life issues that
survivors experience(330).
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The mouse studies performed in this dissertation showed that Merlin is
necessary for proper gland formation. Immunofluorescent stainings show that while
neither YAP nuclear staining nor E-cadherin localization differs between wild-type
and Merlin-deficient endometrial samples, Par3 localization does. This suggests that
loss of apicobasal polarity is necessary for proper endometrial gland formation. A
conditional Par3 knockout within the endometrium would confirm this. In addition, we
would like to manipulate Mullerian duct development culturing techniques to
examine endometrial gland development in real-time. These techniques can also be
utilized to understand the double endometrium phenotype found in a subset of the
Nf2eeKO mice (Figure 21a-c). We hypothesize this phenotype is related to polarized
migration of the Mullerian duct and we can visualize Mullerian duct formation in realtime to determine this.
We can utilize a canonical Wnt signaling reporter mouse (TCF/Lef:H2B-GFP) to
determine where Wnt signaling is increased or decreased within the uterus of the
Nf2eeKO and Nf2seeKO mice(331). Due to some early data on expression of Sox9
in the nuclei of Nf2eeKO and Nf2seeKO luminal epithelium, we are interested to also
examine whether the tissue localization of active canonical Wnt signaling is affected
in the early stages of endometrial gland development. Since it has been shown that
Wnts are specifically active on the antimesometrial side of the uterus(24), we expect
that Merlin may be important for correct localization of Wnt signaling.
In order to determine whether a-catenin is involved in the decrease of Wnt
signaling observed by qRT-PCR, we will examine a-catenin in vivo for changes in
localization. Furthermore, we would like to understand the degree to which actin is
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affected in the Nf2eeKO and Nf2seeKO uteri through both cell culture and potentially
ex vivo studies of endometrial tissue. If we are able to create an ex vivo technique to
culture postnatal tissue, we would like to assess the role of tension in endometrial
gland development as well. To investigate tension, we would utilize blebbistatin, a
myosin II inhibitor, to manipulate actomyosin tension and observe whether glands
are able to form.
In addition, the decidualization-like phenotype observed in Nf2seeKO mice needs
to be further characterized and understood. First, to understand whether this is a
decidualization phenotype, classification of the decidua is necessary. Confirmation
that CD10 (membrane metalloendopeptidase), an endometrial stroma marker, is
decreased and that BMP2 (Bone morphogenetic protein 2) increases will assist in
this process(332). Furthermore, it has been shown that the makeup of immune cells
present in decidua is different than endometrial stroma, specifically there is a
decrease in T- and B-cells(333). Once we have confirmed this is in fact a
spontaneous decidualization affect, we want to better understand the mechanism.
We have hypothesized that since the mice do not begin to exhibit changes in the
uteri until after puberty and it is exacerbated in multiparous females, hormones may
be involved. In order to confirm this first, hormone levels need to be observed in
wild-type versus Nf2seeKO mice. In addition, Nf2seeKO mice should have estradiol
and/or progesterone injected to determine how that affects the uterine tissues. To
determine whether this is a normal phenotype in aged female mice, we will examine
older (1 year to 2 year) uteri for a similar uterus morphology. While we have time
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points that span from day 7 to 6 months of age, potentially more time points between
1 month to 4 months are necessary to understand when the phenotype is initiated.
The question was broached of why we do not see tumor formation. To
understand whether there will be a delayed tumor phenotype like other mutants, we
should examine 12-month time points for potential malignant growths. In addition,
PTEN and Merlin are genetically modified together in all except one EC case that
Merlin is affected in(164, 165). Additionally, polarity and PTEN mutations together
correlate with more invasive tumors then PTEN mutations alone(164, 165). In order
to understand whether PTEN and Merlin work together in tumors, a PTENlox/lox;
Nf2lox/lox; PR-Cre mouse has been generated. Work needs to be done to
characterize whether endometrial cancer is present and if it is more invasive then
PTENlox/lox; PR-Cre mice tumors. This dissertation brings to light a role of Merlin and
apicobasal polarity in endometrial development and homeostasis that needs to be
examined in more detail.
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Chapter 6: Appendix
Mouse Model/
Common Cre

PR-Cre

Wnt7a-Cre
Ctnnb1lox/lox; PR-Cre

Wnt7alox/lox; PR-Cre

Wnt5alox/lox; PR-Cre

Rosa26N1ICD/N1ICD;
PR-Cre

Rosa26N1ICD/N1ICD;
Amhr2-Cre
Ctnnb1lox/lox; PR-Cre

Name used

Description
Progesterone Receptor (PR)- Cre: PR
knockin that appears to start expressing
within the Mullerian duct around
postnatal day 1-5. Expression observed
in the uterus, ovary, oviduct, mammary
gland, and thymus
Wnt7a-Cre: A transgenic mouse line. A
Wnt ligand expressed within the
Mullerian duct epithelium at embryonic
day 12.5. Wnt7a is also expressed
within skin, lungs, limb bud formation,
and neurogenesis.
Ctnnb1lox/lox: Lox/lox targeting exons 2-6
of b-catenin gene.
PR-Cre: previously described (pd)
Wnt7alox/lox: A Wnt ligand that in whole
knockout mouse causes disruption of
parameosnephric duct differentiation.
Lox/lox targets exon 1 and 2 of the
Wnt7a PR-Cre: pd
Wnt5alox/lox: A Wnt ligand that is thought
to be primarily utilized in the noncanonical planar cell polarity pathway.
Lox/lox targted exons 2 and 3 of Wnt5a.
PR-Cre pd
Rosa26N1ICD/N1ICD: Rosa26 promoter
causes ubiquitous and constitute
expression within mice. N1ICD amino
acids 1749-2293
PR-Cre:pd
Rosa26N1ICD/N1ICD: pd
Amhr2-Cre: The Anti-Mullerian
Hormone Receptor Type 2 is necessary
for the differentiation of male
reproductive organs. It is expressed in
the ovarian granulosa cells and in the
female reproductive tract from
embryonic day 12.5. It is specifically
expressed within the myometrium and
endometrial stroma. Cre is knocked
into the Amhr2 locus.
Ctnnb1lox/lox: Lox/lox targeting exons 2-6
of b-catenin gene.
PR-Cre: previously described (pd)

Reference

(249)

(248)
(46, 334)

(290)

(335, 336)

(26, 337)

(338)
(46, 334)
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Ctnnb1f(ex3): Lox/lox targeted the GSK3b phosphorylation site in the 3rd exon
of b-catenin. This phosphorylation is
necessary for degradation.
PR-Cre:pd
Vangl2Lp: Spontaneous point mutation
in the Vangl2 gene that causes an
amino acid change. The heterozygous
mice are called Looptail mice and
exhibited "looped" tails, harelip, cleft
palate, etc. Homozygous mutation
causes the neural tube to be completely
open.
ScribCrc: Circletail mice have a
spontaneous mutation in scribble that
causes craniorachischisis in
homozygous mice. Heterozygous mice
exhibit a kinked tail.

Ctnnb1f(ex3)/+; PRCre

Vangl2Lp/wt

ScribCrc/wt
Dlg3Gt(P038A02)Wrst/Y

Par3DE3/DE3

Par3lox/lox; K14-Cre

aPkcllox/lox; Nphs1Cre

aPkcllox/lox; K5-Cre
Par6atm1.1(KOMP)Vlgcg/tm
1.1(KOMP)Vlcg

APCMin/+; PKCz-/-

Par3eKO

Gene trap vector utilized to mutate Dlg3
Par3DE3/DE3: The exon 3 is deleted in the
Partitioning defective 3 homolog (Par3)
by flanking LoxP sites around exon 3
with a CAG-Cre.
Par3lox/lox: The Par3lox/lox allele utilized in
the Par3DE3/DE3 mouse model. K14-Cre:
the neo version had weak expression in
the basal epidermis and hair follicles.
Expression was stronger after birth in
the basal epidermis and the hair
follicles.
aPKCllox/lox:Lox/lox sites surrounding
exon 5 of PKCl.
Nphs1-Cre: Nphs1 promoter in a Cre
transgene that expresses in the
podocytes.
aPKCllox/lox: pd.
K5-Cre: A transgene containing the
Keratin 5 promoter. K5 expression and
deletion was observed in the basal
epidermis and keratinocytes.
Pard6atm1.1(KOMP)Vlcg: targeted mutation of
Pard6a through a consortium
APC: a multiple intestinal neoplasia
(Min) of the adenomatous polyposis coli
(APC) gene.
PKCz: deletion of PKCz by homologous
recombination

(46)

(339, 340)

(107)
(341)

(133)

(137, 342)

(145, 343,
344)

(345)
(148)

(140, 346,
347)
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Cdh1lox/lox; PR-Cre
Tjp1lox/lox; Nphs1-Cre
Cdh1tm1Cbm/tm1Cbm

Nf2lox/lox; Alb-Cre

Nf2LKO

Nf2lox/lox; Vil-Cre
Nf2lox/lox; K14-Cre

Nf2skinKO

Cdh1lox/lox: E-cadherin gene with lox
sites surrounding exons 6-10;
PR-Cre: pd
Tjp1lox/lox: Lox/lox sites flank exon 4 of
the tight junction protein gene (ZO-1).
Nphs-1-Cre: pd
Cdh1tm1Cbm/tm1Cbm: E-cadherin gene with
a portion of exon 7 and all of exon 8
replaced by a neomycin insert.
Nf2lox/lox: Merlin gene with lox/lox sites
flanking the 2nd exon.
Alb-Cre: A transgenic mouse model
with the liver-specific albuminin
promoter
Nf2lox/lox:pd.
Vil-Cre: Vilin promoter attached to a Cre
showed expression of the Cre within the
cortical renal tubule epithelia

Nf2eeKO

Nf2lox/lox:pd. Wnt7a-Cre:pd

Nf2lox/lox; PR-Cre

Nf2seeKO

Nf2lox/lox: pd. PR-Cre:pd
TCF/Lef:H2B-GFP: TA transgene
containing the Wnt siganling responsive
element, TCF/Lef was bound to
H2B:GFP. Expression is observed
when TCF/Lef are active (or Wnt
signaling is on).
PTENlox/lox: Lox/lox sites flanking PTEN
gene exon 5.
PR-Cre pd

PTENlox/lox; PR-Cre
PTENlox/lox; Nf2lox/lox;
PR-Cre

•
•
•
•
•
•

Nefh-Cre
PO-Cre
P0-Sch-D(39121)
Mx1-Cre
Le-Cre
Vil-CreERT2

Genes in
Table 4 not
described

(213)

(218)

(235, 255,
286)

(349)

Nf2lox/lox:pd. K14-Cre:pd

Nf2lox/lox; Wnt7a-Cre

TCF/Lef:H2B-GFP

(45, 348)

PTENlox/lox: pd. Nf2lox/lox: pd. PR-Cre: pd
Nefh-Cre: A transgenic Cre with the
neurofilament-H gene promoter.
Expression is observed primarily in the
cortex and hippocampal neurons.
PO-Cre:A transgenic Cre with the rat P0
gene. Expression is observed in
Schwann cells.
P0-Sch-D(39-121): A 62kD deletion
mutant that is expressed in the
peripheral nerves.
Mx1-Cre: Mx1 promoter driving Crerecombinase in collecting duct epithelial
cells and a subset of nephrons. Induced
by IFN-a

(331)
(350)

(225, 234,
235, 351,
352)
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Le-Cre: The Le gene promoter is
present on a transgene with Cre.
Expression is initially observed at
embryonic 9 in the lens placode and the
eye lens.
Vil-CreERT2:A tamoxifen inducible
transgene with a Villin gene promoter
bound to a Cre-Estrogen Receptor.

Table 7 Mouse models discussed within the dissertation.
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